Malignant neoplasm of tonsil and base of tongue, including Hilmo

C3_TONSIL_BASEOFTONGUE_WIDE

No definition available.

Endpoint definition

↥

Report an error or suggest an improvement for this endpoint codes

Endpoint definition steps	FinnGen
Phenotype data	557745
1. Apply sex-specific rule None	557745
2. Check conditions None	557745
3. Check pre-conditions, main-only, mode, registry filters Registry filters: Hospital discharge: ICD-10 — C01&, C09 Cause of death: ICD-10 — C01&, C09 Cancer registry: Topography ICD-O-3 — C01\|C09 Cancer registry: Morphology ICD-O-3 — ANY Cancer registry: Behaviour codes — 3 3 out of 7 registries used, show all original rules.	977
4. Check minimum number of events None	977
5. Include endpoints None	977
6. Filter based on genotype QC (FinnGen only)	900

Control definitions (FinnGen only)

Control exclude: C3_CANCER, C3_CANCER_WIDE

Extra metadata

First used in FinnGen datafreeze: DF12

NAME	C3_TONSIL_BASEOFTONGUE_WIDE
CONTROL_EXCLUDE	C3_CANCER\|C3_CANCER_WIDE
CONTROL_PRECONDITIONS
CONTROL_CONDITIONS
SEX
INCLUDE
PRE_CONDITIONS
CONDITIONS
OUTPAT_ICD
OUTPAT_OPER
HD_MAINONLY
HD_ICD_10_ATC
HD_ICD_10	C01\|C09
HD_ICD_9
HD_ICD_8
HD_ICD_10_EXCL
HD_ICD_9_EXCL
HD_ICD_8_EXCL
COD_MAINONLY
COD_ICD_10	C01\|C09
COD_ICD_9
COD_ICD_8
COD_ICD_10_EXCL
COD_ICD_9_EXCL
COD_ICD_8_EXCL
OPER_NOM
OPER_HL
OPER_HP1
OPER_HP2
KELA_REIMB
KELA_REIMB_ICD
KELA_ATC_NEEDOTHER
KELA_ATC
KELA_VNRO_NEEDOTHER
KELA_VNRO
CANC_TOPO	C01\|C09
CANC_TOPO_EXCL
CANC_MORPH	ANY
CANC_MORPH_EXCL
CANC_BEHAV	3

Similar endpoints

↥

List of similar endpoints to Malignant neoplasm of tonsil and base of tongue, including Hilmo based on the number of shared cases.

Similar with more cases:

Similar with less cases:

Case counts by codes

↥

FinnGen case counts by registry codes:

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded (different definition than used in FinnGen).

-FinnGen-

Key figures

	All	Female	Male
Number of individuals	900	273	627
Unadjusted period prevalence (%)	0.23	0.10	0.29
Median age at first event (years)	62.63	63.09	62.42

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log₁₀(p-value) ≥ 6.

Matched cohort

Matched cases
925: Matched controls
9250

Code

Vocabulary

Description

Odds Ratio

-log₁₀(p)

N matched cases

N matched controls

H02AB02

ATC

dexamethasone; systemic

75.3

307.7

280

504

Kela drug reimbursment

Conditions requiring daily forced enteral nutrition

269.2

307.7

381

A03FA01

ATC

metoclopramide; systemic, rectal

27.0

307.7

579

539

JDB10

NOMESCO Finland

Percutaneous gastrostomy

300.9

307.7

342

A04AA01

ATC

ondansetron; systemic, rectal

43.6

307.7

255

EP1AE

NOMESCO Finland

Neck ultrasound examination

24.3

307.7

276

159

C09.0

ICD-10 Finland

Malignant neoplasm: Tonsillar fossa

+∞

307.7

323

WF002

NOMESCO Finland

Radical radiotherapy

1075.1

307.7

383

EMB10

NOMESCO Finland

Tonsillectomy

29.8

307.7

262

121

130

Kela drug reimbursment

Malignant tumour

+∞

307.7

526

UJC01

NOMESCO Finland

Scopy of lower throat

81.8

307.7

184

R22.1

ICD-10 Finland

Localized swelling, mass and lump, neck

25.8

302.4

225

114

XX3DW

NOMESCO Finland

Time consuming IT work

18.9

292.5

257

185

N02AB03

ATC

fentanyl; nasal, sublingual, transdermal

39.4

291.7

184

C01

ICD-10 Finland

Malignant neoplasm of base of tongue

+∞

291.5

264

8070/3-C09.9

ICD-O-3

Squamous cell carcinoma, NOS, of tonsil, NOS

+∞

290.4

263

N02AA05

ATC

oxycodone; systemic

10.6

287.5

461

796

EP1CG

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with high intesity magnet

88.6

281.9

149

R4190

NOMESCO Finland

Nutritional therapy

26.6

271.6

197

WZC20

NOMESCO Finland

Multidisciplinary treatment meeting

30.4

265.2

182

WB103

NOMESCO Finland

Simple adjuvant cytostatic therapy

+∞

257.7

235

C09.9

ICD-10 Finland

Malignant neoplasm: Tonsil, unspecified

+∞

247.3

226

EJA10

NOMESCO Finland

Biopsy of tongue or floor of mouth

33.1

231.8

153

A04AA02

ATC

granisetron; systemic, transdermal

917.0

226.2

213

EN1BD

NOMESCO Finland

Very extensive CT examination of mouth and soft tissues of neck

54.9

223.0

128

GBB00

NOMESCO Finland

Tracheostomy

39.6

199.6

124

WZC00

NOMESCO Finland

Treatment plan or consultation

7.2

198.7

578

1742

ZX012

NOMESCO Finland

Radiotherapy with large shaped fields - isocentric therapy

471.5

197.0

190

GDA98

NOMESCO Finland

Other bronchoscopic incision, excision of lesion or repair of lung

57.8

181.9

103

C77.0

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck

2163.3

181.4

170

WF003

NOMESCO Finland

Adjuvant radiotherapy

+∞

168.0

156

EP1DG

NOMESCO Finland

Very extensive examination of soft tissue of neck with high intesity magnet

93.5

162.2

117

Kela drug reimbursment

Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue

263.4

154.3

154

YA1BD

NOMESCO Finland

Extensive CT examination of head and neck for dose design of radiotherapy

870.0

154.0

147

8070/3-C01.9

ICD-O-3

Squamous cell carcinoma, NOS, of base of tongue, NOS

+∞

152.4

142

C09.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of tonsil

+∞

143.6

134

PJD71

NOMESCO Finland

Extended sparing excision of cervical lymph nodes

+∞

142.5

133

YA1VG

NOMESCO Finland

MRI examination of head and neck with high intesity magnet for dose design of radiotherapy

504.1

134.8

131

UDQ12

NOMESCO Finland

Flexible laryngoscopy

8.3

128.2

190

279

ZX090

NOMESCO Finland

Other technic of radiotherapy

293.9

127.5

127

EN1AD

NOMESCO Finland

CT examination of mouth and soft tissues of neck

33.2

126.4

EBA15

NOMESCO Finland

Extraction of multiple teeth

9.3

121.5

161

206

A07AA02

ATC

nystatin; oral

8.8

119.0

164

220

EMA10

NOMESCO Finland

Biopsy of tonsil

1271.1

117.4

112

WD125

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

1258.2

116.3

111

ZX095

NOMESCO Finland

Combined chemoradiotherapy

+∞

114.0

107

PJD81

NOMESCO Finland

Excision of lymph nodes from upper part of neck

+∞

112.9

106

WZC10

NOMESCO Finland

Written specialist consultation based on a referral from a dentist or a physician

9.5

111.9

144

177

Z51.5

ICD-10 Finland

Palliative care

9.4

111.8

145

180

JN4BD

NOMESCO Finland

Extensive body CT

8.7

108.7

150

201

WW500

NOMESCO Finland

Blood transfusion

17.6

108.4

YA1AD

NOMESCO Finland

CT examination of head and neck for dose design of radiotherapy

394.3

107.7

106

C83.31

ICD-10 Finland

Diffuse lymphoma with large B cells

+∞

103.1

JN6AD

NOMESCO Finland

CT of torso and neck

36.1

101.4

WX408

NOMESCO Finland

General anesthesy, balanced

4.4

100.9

380

1275

SAA03

NOMESCO Finland

Extended examination of mouth

4.1

99.1

538

2330

D10.4

ICD-10 Finland

Benign neoplasm: Tonsil

188.6

98.4

101

GD1BD

NOMESCO Finland

Thorax extensive CT-examination

8.5

98.3

138

188

WZC30

NOMESCO Finland

Teaching

4.9

94.3

265

706

JN5DR

NOMESCO Finland

PET-CT of upper body metabolism

123.0

93.0

R13

ICD-10 Finland

Dysphagia

6.0

91.4

186

374

C44.31

ICD-10 Finland

Basocellular carcinoma of the skin on another or unspecified part of the face

55.0

91.1

WD405

NOMESCO Finland

Simple antiboidy therapy of methastized malignancy

488.6

90.9

UDH02

NOMESCO Finland

Rhinopharyngoscopy

6.3

90.7

172

323

R59.0

ICD-10 Finland

Localized enlarged lymph nodes

13.0

88.7

A04AA55

ATC

palonosetron, combinations; systemic

+∞

86.9

EB1HA

NOMESCO Finland

Panorama tomography of teeth and jaws or similar X-ray examination

3.8

85.3

554

2627

YA1CD

NOMESCO Finland

Very extensive CT examination of head and neck for dose design of radiotherapy

+∞

84.7

ZX070

NOMESCO Finland

Intensity modified radiotherapy

884.9

83.9

R2130

NOMESCO Finland

Counselling and guidance which enhance independent living

5.8

83.5

175

360

WD105

NOMESCO Finland

Cystostatic therapy of methastized malignancy

446.0

83.4

OAB73

NOMESCO Finland

Prevention and treatment of malnutrition

29.2

81.6

A04AD12

ATC

aprepitant; systemic

+∞

81.5

K11.70

ICD-10 Finland

Hypoptyalism

42.1

79.3

UJC02

NOMESCO Finland

Rigid oesophagoscopy

30.6

78.4

ENA10

NOMESCO Finland

Biopsy of pharynx

145.7

76.3

L03AA02

ATC

filgrastim; parenteral

404.1

75.9

Z71.3

ICD-10 Finland

Dietary counselling and surveillance

8.1

73.9

105

144

JN4KR

NOMESCO Finland

Whole body very extensive metabolic PET with CT

203.7

73.3

L03AA13

ATC

pegfilgrastim; parenteral

386.4

72.7

D37.08

ICD-10 Finland

Tumor of uncertain or unknown nature in other part of lip, oral cavity and pharynx

163.0

72.1

K08.1

ICD-10 Finland

Loss of teeth due to accident, extraction or local periodontal disease

4.1

71.8

245

743

C02.11

ICD-10 Finland

Malignant neoplasm of border of tongue

+∞

70.7

9680/3-C09.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of tonsil, NOS

+∞

69.7

EBA10

NOMESCO Finland

Operative extraction of tooth

4.6

69.3

194

506

WX402

NOMESCO Finland

General anaesthesia

3.6

67.9

297

1064

JCW98

NOMESCO Finland

Other transluminal endoscopic procedure on oesophagus

+∞

66.5

Z50.8

ICD-10 Finland

Care involving use of other rehabilitation procedures

5.0

65.0

156

358

C61

ICD-10 Finland

Malignant neoplasm of prostate

346.8

64.3

8070/3-C09.0

ICD-O-3

Squamous cell carcinoma, NOS, of tonsillar fossa

+∞

63.3

8140/3-C61.9

ICD-O-3

Adenocarcinoma, NOS, of prostate gland

+∞

62.2

SBB00

NOMESCO Finland

Clinical photography of mouth and teeth

9.2

61.8

C79.8

ICD-10 Finland

Secondary malignant neoplasm of other specified sites

+∞

61.1

QAE10

NOMESCO Finland

Excision of other lesion extending through all layers of skin in head or neck

6.8

59.8

160

JN4JR

NOMESCO Finland

Whole body extensive metabolic PET with CT

163.0

58.6

SBB10

NOMESCO Finland

Dental impressions

5.7

58.1

118

233

J35.1

ICD-10 Finland

Hypertrophy of tonsils

17.4

57.7

WD415

NOMESCO Finland

Demanding antibody therapy of methastized malignancy

299.0

55.8

EB1BI

NOMESCO Finland

Cone beam imaging of teeth and jaws (1–2 quarters)

12.6

55.3

XW000

NOMESCO Finland

Bone marrow biopsy

8.9

55.0

WF049

NOMESCO Finland

Radiotherapy of metastasis

293.1

54.8

ZZQ00

NOMESCO Finland

Free microvascular graft of skin

559.3

54.1

WZC05

NOMESCO Finland

Specialty-specific consultation based on referral by dentist or doctor

6.0

52.5

182

JN4AD

NOMESCO Finland

Body CT examination

4.7

52.4

134

322

EJB20

NOMESCO Finland

Excision of tumor or other lesion of base of tongue

275.5

51.7

SCA02

NOMESCO Finland

Preventive oral health care

4.4

51.2

143

368

ZX120

NOMESCO Finland

Intravenous

4.8

51.0

126

294

A06AD11

ATC

lactulose; oral

3.4

49.0

218

773

H03AA01

ATC

levothyroxine sodium; systemic

3.1

48.6

266

1066

R4130

NOMESCO Finland

Speech therapy

7.2

48.1

110

SXC03

NOMESCO Finland

Other oral or dental procedure

15.0

47.9

PJD51

NOMESCO Finland

Block dissection of cervical lymph nodes

+∞

47.3

8090/3-C44.9

ICD-O-3

Basal cell carcinoma, NOS, of skin, NOS

+∞

46.2

GD1AD

NOMESCO Finland

Thorax CT examination

4.6

46.1

118

283

TJD00

NOMESCO Finland

Insertion of nasogastric or naso-gastroduodenal tube

15.4

45.3

YX9AD

NOMESCO Finland

Other CT eamination for dose design of radiotherapy

161.2

44.2

C78.0

ICD-10 Finland

Secondary malignant neoplasm of lung

+∞

43.1

R07.0

ICD-10 Finland

Pain in throat

4.6

41.5

106

253

UDQ22

NOMESCO Finland

Microlaryngoscopy

14.1

41.0

TJD20

NOMESCO Finland

Change of gastrostomy tube

78.9

40.3

UGC12

NOMESCO Finland

Flexible bronchoscopy

4.0

40.1

126

352

WF004

NOMESCO Finland

Palliative radiotherapy

+∞

39.9

GD1AA

NOMESCO Finland

Thorax X-ray examination

2.5

39.8

551

3430

TPX10

NOMESCO Finland

Implantation of vascular injection port

8.8

39.8

T05

ICPC

Feeding problem of adult

16.0

39.3

EB1CI

NOMESCO Finland

Cone beam imaging of teeth and jaws (3-4 quarters)

13.7

39.3

EBB10

NOMESCO Finland

Insertion of dental implant

11.0

37.8

SCA03

NOMESCO Finland

Preventive oral health care, extensive

5.5

37.4

149

ENB20

NOMESCO Finland

Pharyngectomy

371.2

36.2

WB113

NOMESCO Finland

Multiple adjuvant cytostatic therapy

+∞

35.7

TPH30

NOMESCO Finland

Insertion of central venous catheter through periferal vein

8.2

35.6

WX002

NOMESCO Finland

Sedation and analgesia

2.7

34.1

241

1083

116

Kela drug reimbursment

Prostate cancer

+∞

33.5

TPH20

NOMESCO Finland

Insertion of central venous catheter through subclavian or brachiocephalic vein

7.7

32.9

PJ3AT

NOMESCO Finland

Cytology of lymphnode with ultrasound guidance

38.9

32.7

ZXE30

NOMESCO Finland

More than five and less than seven hours

5.1

32.6

148

YX9BD

NOMESCO Finland

Other extensive CT eamination for dose design of radiotherapy

+∞

32.5

9591/3-C09.9

ICD-O-3

Malignant lymphoma, non-Hodgkin, NOS, of tonsil, NOS

+∞

32.5

Z51.1

ICD-10 Finland

Chemotherapy session for neoplasm

327.9

32.1

ZXE50

NOMESCO Finland

More than nine and less than 12 hours

10.4

32.0

SBA00

NOMESCO Finland

Microbiological examinations

7.0

31.7

WX404

NOMESCO Finland

Intravenous generell anesthesy

2.7

31.5

200

848

SCA04

NOMESCO Finland

Guidance on care of mouth and oral mucosa

55.0

31.5

C85.9

ICD-10 Finland

Non-Hodgkin lymphoma, unspecified

+∞

31.4

D70.82

ICD-10 Finland

Drug-induced neutropenia

48.1

30.8

SAA04

NOMESCO Finland

Special examination of mouth

4.3

30.8

206

115

Kela drug reimbursment

Breast cancer

+∞

30.4

PJA12

NOMESCO Finland

Sentinel node biopsy

+∞

30.4

WD115

NOMESCO Finland

Multiple cystostatic therapy of methastized malignancy

+∞

30.4

XZZ00

NOMESCO Finland

Active surveillance of a diagnosed cancer

+∞

30.4

RD210, ,

NOMESCO Finland

9.0

30.3

Z3226

NOMESCO Finland

Physiotherapist

2.6

30.0

208

920

K04.5

ICD-10 Finland

Chronic apical periodontitis

2.3

29.8

342

1897

TPH07

NOMESCO Finland

Cathetrisation of artery

3.0

29.6

149

557

K05.31

ICD-10 Finland

Periodontitis pronounced

2.8

29.3

179

742

WB101

NOMESCO Finland

Simple cytostatic neoadjuvant therapy

+∞

29.3

8085/3-C09.9

ICD-O-3

Squamous cell carcinoma, HPV positive of tonsil, NOS

+∞

29.3

R4110

NOMESCO Finland

Physiotherapy

2.3

29.0

298

1574

QA1S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head

35.0

28.9

ZXE00

NOMESCO Finland

One hour or less

2.2

28.8

379

2215

R22.0

ICD-10 Finland

Localized swelling, mass and lump, head

5.8

28.8

PJD41

NOMESCO Finland

Excision of cervical lymph nodes

30.4

28.7

TPH04

NOMESCO Finland

Cathetrisation of vein

2.4

28.6

249

1223

K10.26

ICD-10 Finland

Periostitis of jaw (acute)(chronic)(suppurative)

+∞

28.3

ZZA00

NOMESCO Finland

Split skin graft

6.5

28.1

A49.9

ICD-10 Finland

Bacterial infection, unspecified

3.0

28.0

140

521

ENB00

NOMESCO Finland

Excision or exploration of lesion of pharynx

289.9

27.9

B01AB10

ATC

tinzaparin; parenteral

3.2

27.7

119

405

A02BC05

ATC

esomeprazole; systemic

2.1

27.6

438

2742

WX110

NOMESCO Finland

Infiltration anesthesia

2.3

27.3

681

5069

C83.1

ICD-10 Finland

Mantle cell lymphoma

+∞

27.2

D10.10

ICD-10 Finland

Benign tumor at the base of the tongue

77.6

26.9

ZXE40

NOMESCO Finland

More than seven and less than nine hours

7.1

26.9

ECB20

NOMESCO Finland

Oral alveoplasty

9.7

26.3

GD1UA

NOMESCO Finland

Thorax X-ray examination outside radiological department

2.4

26.2

226

1101

C02.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of tongue

+∞

26.2

ZXD30

NOMESCO Finland

Difficulties in perfomrming procedure

4.6

26.1

151

WD325

NOMESCO Finland

Demanding therapy of methastized malignancy with biomodifiers

267.8

25.8

Z2221

NOMESCO Finland

Medical doctor

2.3

25.6

265

1393

SXB00

NOMESCO Finland

Removal of sutures from oral mucosa

3.3

25.4

101

327

SXC02

NOMESCO Finland

Other oral or dental procedure, restricted

5.6

25.2

UJD10

NOMESCO Finland

Esophagoscopy, gastroscopy and duodenoscopy

2.1

25.1

322

1842

8085/3-C01.9

ICD-O-3

Squamous cell carcinoma, HPV positive of base of tongue, NOS

+∞

25.1

WD305

NOMESCO Finland

Simple therapy of methastized malignancy with biomodifiers

+∞

25.1

WD135

NOMESCO Finland

Demanding cystostatic therapy of methastized malignancy

+∞

25.1

Z2446

NOMESCO Finland

Social worker

3.7

24.7

236

ED1AA

NOMESCO Finland

Mandibular X-ray examination

28.5

24.6

ZX080

NOMESCO Finland

Image guided radiotherapy

+∞

24.1

C09.1

ICD-10 Finland

Malignant neoplasm: Tonsillar pillar (anterior)(posterior)

+∞

24.1

EMB00

NOMESCO Finland

Excision of lesion of tonsil or adenoids

69.3

23.9

Z43.1

ICD-10 Finland

Attention to gastrostomy

128.3

23.7

K13.79

ICD-10 Finland

Change in the oral mucosa UNS

4.9

23.6

113

EBB15

NOMESCO Finland

Insertion of dental implant abutment

22.0

23.6

J02AC01

ATC

fluconazole; systemic

2.1

23.1

316

1841

ZXD10

NOMESCO Finland

Scheduled procedure

2.0

23.0

360

2204

A02BC02

ATC

pantoprazole; systemic

2.1

22.8

664

5051

WX302

NOMESCO Finland

Thoracal epidural anesthesy

5.4

22.7

TDW99

NOMESCO Finland

Other minor procedure in surgery of ear, nose and larynx

4.4

22.7

142

K11.71

ICD-10 Finland

Xerostomy (dry mouth)

9.2

22.2

8090/3-C44.3

ICD-O-3

Basal cell carcinoma, NOS, of skin of other and unspecified parts of face

+∞

22.0

9673/3-C09.9

ICD-O-3

Mantle cell lymphoma of tonsil, NOS

+∞

22.0

EJB40

NOMESCO Finland

Hemiglossectomy

+∞

22.0

C09

ICD-10 Finland

Malignant neoplasm of tonsil

+∞

22.0

UJC20

NOMESCO Finland

Extensive endoscopy to identify diagnosed or suspected primary malignant neoplasm of head or neck

+∞

22.0

EDB00

NOMESCO Finland

Partial excision of mandible

+∞

22.0

ZXE10

NOMESCO Finland

More than one and less than three hours

2.0

21.9

340

2067

K13.78

ICD-10 Finland

Other change in the oral mucosa

5.3

21.6

ZXE20

NOMESCO Finland

More than three and less than five hours

2.6

21.6

147

637

K08.3

ICD-10 Finland

Retained dental root

2.8

21.1

119

470

Z51.0

ICD-10 Finland

Radiotherapy session

+∞

20.9

C78.7

ICD-10 Finland

Secondary malignant neoplasm of liver and intrahepatic bile duct

+∞

20.9

L01BC06

ATC

capecitabine; oral

+∞

20.9

JC2KB

NOMESCO Finland

Functional X-ray examination of swallowing

7.3

20.9

RD160, ,

NOMESCO Finland

78.7

20.8

ZXC96

NOMESCO Finland

Robot assisted procedure

30.8

20.6

EP1BG

NOMESCO Finland

MRI examination of soft tissue of neck with high intesity magnet

42.7

20.5

PJA10

NOMESCO Finland

Exploration of lymph nodes

20.6

20.5

JN4CD

NOMESCO Finland

Very extensive body CT

7.3

20.4

QAA05

NOMESCO Finland

Incision for biopsy of skin of head or neck

8.1

20.1

Z3231

NOMESCO Finland

Registered nurse

2.1

20.0

260

1474

C83.3

ICD-10 Finland

Diffuse large B-cell lymphoma

+∞

19.9

SPA00

NOMESCO Finland

Changing form of teeth in prepation for prosthodontic work

3.6

19.8

195

ENB99

NOMESCO Finland

Other excision of pharynx and adjacent structures

75.2

19.8

D37.09

ICD-10 Finland

Lip, oral cavity and pharynx

107.4

19.6

OAB74

NOMESCO Finland

Nutritional guidance related to treatment and rehabilitation for medical condition

7.9

19.6

ENB40

NOMESCO Finland

Excision of branchial cyst or fistula

41.0

19.6

GD6AD

NOMESCO Finland

CT of chest and neck

47.1

19.3

R21

ICPC

Throat symptom/complaint

2.3

19.2

174

856

B01AB05

ATC

enoxaparin; parenteral

2.0

18.9

283

1682

QBB10

NOMESCO Finland

Major dressing of wound of skin of trunk

4.9

18.9

C02.4

ICD-10 Finland

Malignant neoplasm: Lingual tonsil

+∞

18.8

EJB30

NOMESCO Finland

Excision of tumor or other lesion of floor of the mouth

+∞

18.8

XW1AT

NOMESCO Finland

Biopsy from other organ close to skin with ultrasound quidance

28.5

18.8

SXA10

NOMESCO Finland

Oral mucosal sampling

7.5

18.7

WX707

NOMESCO Finland

Fiberoscopic intubation

39.3

18.6

EP1CM

NOMESCO Finland

Extensive MRI examination of soft tissue of neck with 3 Tesla magnet

193.8

18.6

K05.30

ICD-10 Finland

Periodontitis complex

2.2

18.5

187

961

K12.10

ICD-10 Finland

Stomatitis NOS

30.7

18.4

UJC12

NOMESCO Finland

Flexible oesophagoscopy

13.9

18.3

Q18.0

ICD-10 Finland

Sinus, fistula and cyst of branchial cleft

25.6

18.3

EB1WA, ,

NOMESCO Finland

14.1

17.9

C02.9

ICD-10 Finland

Malignant neoplasm: Tongue, unspecified

+∞

17.8

C04.0

ICD-10 Finland

Malignant neoplasm: Anterior floor of mouth

+∞

17.8

8500/3-C50.9

ICD-O-3

Infiltrating duct carcinoma, NOS, of breast, NOS

+∞

17.8

GD5BD

NOMESCO Finland

Thorax and upper abdomen combined extensive CT examination of

7.2

17.4

C44.51

ICD-10 Finland

Basocellular carcinoma of the skin on the torso

42.9

17.3

JN5KR

NOMESCO Finland

Very extensive PET-CT of upper body metabolism (eyebrows to thighs)

42.9

17.3

EB1BA

NOMESCO Finland

Extensive intraoral X-ray examination

32.1

17.1

WX105

NOMESCO Finland

Surface analgesia on skin or mucosa

2.5

17.1

120

526

JN6BD

NOMESCO Finland

Extensive CT of torso and neck

26.2

17.0

EBA00

NOMESCO Finland

Extraction of tooth

1.8

17.0

368

2452

K05.10

ICD-10 Finland

Gingivitis (chronic) NOS

2.2

16.9

158

784

C02.10

ICD-10 Finland

Malignant neoplasm of tip of tongue

+∞

16.7

8070/3-C02.1

ICD-O-3

Squamous cell carcinoma, NOS, of border of tongue

+∞

16.7

L03AA14

ATC

lipegfilgrastim; parenteral

+∞

16.7

PJD91

NOMESCO Finland

Excision of lymph nodes in neck, 1 to 2 areas in total

+∞

16.7

C50.41

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, ductal tumor

+∞

16.7

KEC01

NOMESCO Finland

Percutaneous endoscopic radical prostatectomy

+∞

16.7

HAC20

NOMESCO Finland

Total mastectomy

173.0

16.5

A79

ICPC

Malignancy NOS

173.0

16.5

YG1BD

NOMESCO Finland

Extensive CT examination of thorax for dose design of radiotherapy

173.0

16.5

EBA12

NOMESCO Finland

Demanding operative extraction of tooth

5.2

16.3

WZB00

NOMESCO Finland

Telephone prescription or other care instructions

1.9

16.3

266

1617

TQW99

NOMESCO Finland

Other minor procedure on skin

3.7

16.2

151

K02.1

ICD-10 Finland

Caries of dentine

1.8

16.1

540

4073

K08.2

ICD-10 Finland

Atrophy of edentulous alveolar ridge

6.5

15.9

212

Kela drug reimbursment

Gout

5.0

15.8

L02AE02

ATC

leuprorelin; implant, parenteral

34.0

15.8

XQ902

NOMESCO Finland

Other photography

7.3

15.7

EBB11

NOMESCO Finland

Insertion of additional dental implant in one session

17.6

15.7

C10.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of oropharynx

+∞

15.7

GDC01

NOMESCO Finland

Thoracoscopic lobectomy of lung

+∞

15.7

C83.9

ICD-10 Finland

Non-follicular (diffuse) lymphoma, unspecified

+∞

15.7

R50.9

ICD-10 Finland

Fever, unspecified

2.2

15.5

149

746

D77

ICPC

Malignant digestive neopl other/NOS

162.6

15.5

UDQ02

NOMESCO Finland

Direct laryngoscopy

12.6

15.4

EDW99

NOMESCO Finland

Other operation on mandible

38.8

15.4

XX2RW, ,

NOMESCO Finland

15.1

15.4

GD1PA

NOMESCO Finland

X-ray examination of the lungs in one projection

2.3

15.1

121

562

SDA03

NOMESCO Finland

Periodontal treatment

1.8

15.0

373

2563

EE1AA

NOMESCO Finland

X-ray of upper jaw or palate

32.3

14.8

R22.9

ICD-10 Finland

Localized swelling, mass and lump, unspecified

2.6

14.8

356

EJB10

NOMESCO Finland

Excision of tumor or other lesion of apex or body of tongue

25.5

14.7

E03.9

ICD-10 Finland

Hypothyroidism, unspecified

2.3

14.7

115

528

8070/3-C02.9

ICD-O-3

Squamous cell carcinoma, NOS, of tongue, NOS

+∞

14.6

WW300

NOMESCO Finland

Transfer of autologic stem cells

+∞

14.6

R85

ICPC

Malignant neopl respiratory other

152.3

14.5

N05CF01

ATC

zopiclone; oral

1.8

14.3

305

1998

SPA20

NOMESCO Finland

Selection and insertion of implant abutment

22.7

14.3

SXC05

NOMESCO Finland

Other oral or dental procedure

2.9

14.2

256

D21

ICPC

Swallowing problem

4.9

14.1

AA3AI

NOMESCO Finland

Cone beam CT of facial bones

6.8

14.1

ZXB10

NOMESCO Finland

Medial

16.1

14.0

D38.1

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung

6.1

13.9

EB1AI

NOMESCO Finland

Cone beam imaging of teeth and jaws (one quarter)

4.8

13.8

EHA10

NOMESCO Finland

Biopsy of palate

15.0

13.6

D10.9

ICD-10 Finland

Benign neoplasm: Pharynx, unspecified

76.3

13.6

C82.1

ICD-10 Finland

Follicular lymphoma grade II

+∞

13.6

C79.5

ICD-10 Finland

Secondary malignant neoplasm of bone and bone marrow

+∞

13.6

C32.9

ICD-10 Finland

Malignant neoplasm: Larynx, unspecified

+∞

13.6

C03.1

ICD-10 Finland

Malignant neoplasm: Lower gum

+∞

13.6

C67.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of bladder

+∞

13.6

C90.0

ICD-10 Finland

Multiple myeloma

+∞

13.6

C32.0

ICD-10 Finland

Malignant neoplasm: Glottis

+∞

13.6

SDA02

NOMESCO Finland

Periodontal treatment, brief

1.7

13.5

322

2172

XX1AD

NOMESCO Finland

Other CT-examination

142.0

13.5

TQX10

NOMESCO Finland

Biopsy of skin and subcutaneous tissue

2.6

13.4

312

WZC15, ,

NOMESCO Finland

40.7

13.2

D10.5

ICD-10 Finland

Benign neoplasm: Other parts of oropharynx

40.7

13.2

PJ2AT

NOMESCO Finland

Biopsy of lymphnode with ultrasound guidance

40.7

13.2

EB1JA

NOMESCO Finland

Double panorama tomography of teeth and jaws or similar X-ray examination

10.2

13.0

M04AA01

ATC

allopurinol; systemic

2.0

13.0

153

825

SBA10

NOMESCO Finland

Measurement of salivary flow rate

6.2

13.0

GD1CT

NOMESCO Finland

Biopsy of the lung with CT guidance

19.4

12.9

C91.1

ICD-10 Finland

Chronic lymphocytic leukaemia of B-cell type

50.7

12.9

J01DB01

ATC

cefalexin; oral

1.9

12.8

749

6408

JN3AE

NOMESCO Finland

Abdominal ultrasound examination

2.2

12.8

122

608

TPH15

NOMESCO Finland

Insertion of central venous catheter through external or internal jugular vein

2.8

12.7

243

JN3AD

NOMESCO Finland

Abdominal CT examination

2.1

12.6

125

631

QA7S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in jaw or lips

70.9

12.6

JN4DR

NOMESCO Finland

Whole body metabolic PET with CT

70.9

12.6

SPA60

NOMESCO Finland

Fitting of intermediary dental prosthesis structures, 1 to 3 units

4.2

12.6

C83.39

ICD-10 Finland

Diffuse non-Hodgkin's large cell lymphoma UNS

+∞

12.5

C64.88

ICD-10 Finland

Other malignant neoplasm of kidney, except renal pelvis

+∞

12.5

C13.9

ICD-10 Finland

Malignant neoplasm: Hypopharynx, unspecified

+∞

12.5

C50.99

ICD-10 Finland

Breast, unspecified

+∞

12.5

WB121

NOMESCO Finland

Demanding neoadjuvant cytostatic therapy

+∞

12.5

C10.2

ICD-10 Finland

Malignant neoplasm: Lateral wall of oropharynx

+∞

12.5

C85.1

ICD-10 Finland

B-cell lymphoma, unspecified

+∞

12.5

B37.0

ICD-10 Finland

Candidal stomatitis

6.3

12.5

ZZR00

NOMESCO Finland

Flap of skin

20.4

12.5

Y77

ICPC

Malignant neoplasm prostate

131.7

12.5

ZX050

NOMESCO Finland

Stereotactic radiotherapy

131.7

12.5

K02.9

ICD-10 Finland

Dental caries, unspecified

5.2

12.3

TJW99

NOMESCO Finland

Other minor procedure in gastrointestinal endoscopy

38.1

12.2

HA1AE

NOMESCO Finland

Ultrasound examination of mammary glands

4.7

12.2

ZXF99

NOMESCO Finland

Other r3eason to interrupt procedure

18.3

12.1

ZXC10

NOMESCO Finland

Use of laser

4.1

12.0

L02BA01

ATC

tamoxifen; oral

47.3

11.9

K13.29

ICD-10 Finland

Indefinite leukoplakia

5.9

11.8

D10.19

ICD-10 Finland

Benign tumor of the tongue UNS

14.9

11.8

JCA55

NOMESCO Finland

Endoscopic dilatation of oesophagus

10.7

11.8

L02BG04

ATC

letrozole; oral

16.7

11.7

GD6BD

NOMESCO Finland

Extensive CT of chest and neck

30.5

11.7

EWE00

NOMESCO Finland

Reoperation for deep haemorrhage in surgery of teeth, jaws, mouth and pharynx

65.8

11.6

S04

ICPC

Lump/swelling localized

2.2

11.6

103

498

D38.0

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Larynx

23.2

11.6

XX1XW

NOMESCO Finland

Extensive written report from radiologist

4.5

11.5

TNE25

NOMESCO Finland

Drill biopsy of bone marrow, pelvis

13.8

11.5

WB401

NOMESCO Finland

Simple antibody therapy of primary tumour

+∞

11.5

WB123

NOMESCO Finland

Demanding adjuvant cytostatic therapy

+∞

11.5

C10.9

ICD-10 Finland

Malignant neoplasm: Oropharynx, unspecified

+∞

11.5

C05.1

ICD-10 Finland

Malignant neoplasm: Soft palate

+∞

11.5

C20.91

ICD-10 Finland

Malignant tumor of the rectum invasive carcinoma

+∞

11.5

C73.91

ICD-10 Finland

Papillary carcinoma of the thyroid gland (thyroid gland)

+∞

11.5

8140/3-C20.9

ICD-O-3

Adenocarcinoma, NOS, of rectum, NOS

+∞

11.5

C13.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of hypopharynx

+∞

11.5

8085/3-C09.0

ICD-O-3

Squamous cell carcinoma, HPV positive of tonsillar fossa

+∞

11.5

C10.0

ICD-10 Finland

Malignant neoplasm: Vallecula

+∞

11.5

EP1DM

NOMESCO Finland

Very extensive MRI examination of soft tissue of neck with 3 Tesla magnet

121.5

11.4

K02.2

ICD-10 Finland

Caries of cementum

2.7

11.2

247

SPF00

NOMESCO Finland

Reparation of dental prosthesis without impressions

3.6

11.2

106

WX199

NOMESCO Finland

Other local analgesia

3.1

11.2

152

A06AH03

ATC

naloxegol; oral

12.9

11.2

KCD02

NOMESCO Finland

Transurethral resection of bladder

25.4

11.2

T81.4

ICD-10 Finland

Infection following a procedure, not elsewhere classified

2.2

11.0

102

501

QAB05

NOMESCO Finland

Revision of wound of skin of head or neck

43.9

10.9

J35.9

ICD-10 Finland

Chronic disease of tonsils and adenoids, unspecified

43.9

10.9

QAE99

NOMESCO Finland

Other excision or repair surgery of skin and subcutaneous tissue in head and neck

5.5

10.9

D11.0

ICD-10 Finland

Benign neoplasm: Parotid gland

4.3

10.9

DQA10

NOMESCO Finland

Biopsy of larynx

15.7

10.9

ECA20

NOMESCO Finland

Biopsy of gingiva

8.4

10.8

Z01.2

ICD-10 Finland

Dental examination

1.6

10.8

390

2890

ZXE11

NOMESCO Finland

Procedure duration 60 to 89 minutes

2.9

10.7

178

K02.0

ICD-10 Finland

Caries limited to enamel

1.9

10.7

160

933

ZXA00

NOMESCO Finland

Right side

1.7

10.7

245

1619

R11

ICD-10 Finland

Nausea and vomiting

2.4

10.4

344

Z93.1

ICD-10 Finland

Gastrostomy status

111.2

10.4

C32.8

ICD-10 Finland

Malignant neoplasm: Overlapping lesion of larynx

+∞

10.4

PJD52

NOMESCO Finland

Block dissection of axillary lymph nodes

+∞

10.4

EP1KS

NOMESCO Finland

Very extensive PET-MRI of neck metabolism

+∞

10.4

C04.1

ICD-10 Finland

Malignant neoplasm: Lateral floor of mouth

+∞

10.4

8070/3-C44.9

ICD-O-3

Squamous cell carcinoma, NOS, of skin, NOS

+∞

10.4

JN5AP

NOMESCO Finland

Total body PET (1 picture)

+∞

10.4

JN1AE

NOMESCO Finland

Ultrasound examination of upper part of abdomen

2.3

10.4

384

ZXA05

NOMESCO Finland

Left side

1.7

10.4

221

1429

1XC02, ,

NOMESCO Finland

16.2

10.4

SBB20

NOMESCO Finland

Tooth X-ray examination in conjunction with visit to dentist

5.2

10.3

ZX112

NOMESCO Finland

Subcutaneous

10.8

10.3

R91

ICD-10 Finland

Abnormal findings on diagnostic imaging of lung

2.1

10.3

487

SCA01

NOMESCO Finland

Preventive oral health care, short

1.7

10.2

225

1467

EP1AE, ,

SPAT

4.2

10.2

A41.9

ICD-10 Finland

Sepsis, unspecified

3.2

10.2

134

JN3BD

NOMESCO Finland

Extensive abdominal CT

2.2

10.2

421

HA1AA

NOMESCO Finland

X-ray mammography

3.8

10.1

B37.08

ICD-10 Finland

Other candidal stomatitis

8.6

10.1

J01MA12

ATC

levofloxacin; systemic

1.8

10.1

170

1027

C44.41

ICD-10 Finland

Basocellular carcinoma of the skin of the scalp and neck

40.5

10.0

ZXA10

NOMESCO Finland

Bilateral

1.8

9.9

164

984

IAZ97

NOMESCO Finland

Psychiatric consultation in another specialty

7.7

9.9

EDA10

NOMESCO Finland

Biopsy of mandible

26.3

9.8

SPA02

NOMESCO Finland

Preparation for dental prosthetics

2.9

9.8

159

KE1AT

NOMESCO Finland

Biopsy of prostata with ultrasoudnguidance

3.3

9.7

117

SPC10

NOMESCO Finland

Standard dental crown

4.3

9.7

JDB00

NOMESCO Finland

Gastrostomy

55.6

9.7

J01CE02

ATC

phenoxymethylpenicillin; oral

1.6

9.7

588

4865

WX602

NOMESCO Finland

Repeated or continuing anesthesia shots throug a catheter

2.8

9.6

177

J01EE01

ATC

sulfamethoxazole and trimethoprim; systemic

2.6

9.6

218

J18.9

ICD-10 Finland

Pneumonia, unspecified

1.6

9.4

247

1681

WVC10

NOMESCO Finland

Subcutaneous infusion of drugs

17.7

9.4

TJD10

NOMESCO Finland

Insertion of other tube into stomach or duodenum

30.4

9.4

8260/3-C73.9

ICD-O-3

Papillary adenocarcinoma, NOS, of thyroid gland

+∞

9.4

C02.2

ICD-10 Finland

Malignant neoplasm: Ventral surface of tongue

+∞

9.4

C02.0

ICD-10 Finland

Malignant neoplasm: Dorsal surface of tongue

+∞

9.4

C02.1

ICD-10 Finland

Malignant neoplasm: Border of tongue

+∞

9.4

GB3AV, ,

NOMESCO Finland

+∞

9.4

YX9AW, ,

NOMESCO Finland

+∞

9.4

EJB60

NOMESCO Finland

Partial excision of floor of mouth

+∞

9.4

1460A

ICD-9 Finland

Malignant neoplasm of oropharynx, Tonsil

+∞

9.4

Z85.7

ICD-10 Finland

Personal history of other malignant neoplasms of lymphoid, haematopoietic and related tissues

+∞

9.4

C34.11

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary epidermoid carcinoma

+∞

9.4

HA003

NOMESCO Finland

Radiotherapy after partial ablation of mammary gland

+∞

9.4

YG1AD

NOMESCO Finland

CT examination of thorax for dose design of radiotherapy

+∞

9.4

UDQ42

NOMESCO Finland

Endoscopic assessment of swallowing function

10.8

9.3

R68.2

ICD-10 Finland

Dry mouth, unspecified

13.8

9.2

L57.0

ICD-10 Finland

Actinic keratosis

2.2

9.2

397

ZXD05

NOMESCO Finland

Urgent procedure

1.6

9.1

255

1763

N02AA01

ATC

morphine; systemic, rectal

4.8

9.1

D14.1

ICD-10 Finland

Benign neoplasm: Larynx

11.6

9.1

JDB01

NOMESCO Finland

Laparoscopic gastrostomy

37.1

9.0

R59.1

ICD-10 Finland

Generalized enlarged lymph nodes

7.5

9.0

HAB40

NOMESCO Finland

Wedge excision of mammary gland

18.8

8.9

QA4S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in face

24.3

8.9

SPD01

NOMESCO Finland

Mucosa-supported complete denture

4.7

8.9

E03.89

ICD-10 Finland

Other specified hypothyroidism

3.2

8.8

108

J36

ICD-10 Finland

Peritonsillar abscess

3.4

8.8

K11.2

ICD-10 Finland

Sialoadenitis

3.0

8.8

135

AA1BD

NOMESCO Finland

Extensive CT of head and brain

4.2

8.8

SPE02

NOMESCO Finland

Metal-framed partial denture

3.6

8.7

N02BE01

ATC

paracetamol; systemic, rectal

1.8

8.7

803

7246

XX3ZW, ,

NOMESCO Finland

50.5

8.7

UGC02

NOMESCO Finland

Rigid bronchoscopy

50.5

8.7

D10.7

ICD-10 Finland

Benign neoplasm: Hypopharynx

50.5

8.7

J03.9

ICD-10 Finland

Acute tonsillitis, unspecified

3.1

8.7

120

J39.2

ICD-10 Finland

Other diseases of pharynx

7.0

8.6

ZZF00

NOMESCO Finland

Graft of adipose tissue

16.5

8.6

ZZR30

NOMESCO Finland

Flap of muscle

27.8

8.5

308

Kela drug reimbursment

Alprostadil, sildenafil and combination product containing aviptadil and phentolamine

20.2

8.5

Z08.7

ICD-10 Finland

Follow-up examination after combined treatment for malignant neoplasm

90.9

8.4

C20.90

ICD-10 Finland

Malignant tumor of the rectum without histology

90.9

8.4

C67.9

ICD-10 Finland

Malignant neoplasm: Bladder, unspecified

90.9

8.4

Z08.0

ICD-10 Finland

Follow-up examination after surgery for malignant neoplasm

90.9

8.4

K03.66

ICD-10 Finland

Tooth plaque

2.1

8.4

377

SPA51

NOMESCO Finland

Determination of bite and dental arch location, demanding

4.5

8.4

ZXE04

NOMESCO Finland

Procedure duration 30 to 39 minutes

2.5

8.4

221

C34.10

ICD-10 Finland

Malignant tumor of the upper lobe, bronchus or lung without histology

+∞

8.3

4707

FHL

Dissection Colli radicalis

+∞

8.3

C50.40

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, no histological veryfication

+∞

8.3

8083/3-C09.9

ICD-O-3

Basaloid squamous cell carcinoma of tonsil, NOS

+∞

8.3

9823/3-C09.9

ICD-O-3

B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma of tonsil, NOS

+∞

8.3

C04.9

ICD-10 Finland

Malignant neoplasm: Floor of mouth, unspecified

+∞

8.3

QA9S1

NOMESCO Finland

Photography of skin or subcutaneous tissue in head or neck, unspecified

+∞

8.3

C18.71

ICD-10 Finland

Malignant tumor of the sigmoid invasive carcinoma

+∞

8.3

9691/3-C09.9

ICD-O-3

Follicular lymphoma, grade 2 of tonsil, NOS

+∞

8.3

8500/3-C50.4

ICD-O-3

Infiltrating duct carcinoma, NOS, of upper-outer quadrant of breast

+∞

8.3

EJC99

NOMESCO Finland

Other reconstructive operations on tongue and floor of mouth

+∞

8.3

8090/3-C44.5

ICD-O-3

Basal cell carcinoma, NOS, of skin of trunk

+∞

8.3

8070/3-C04.9

ICD-O-3

Squamous cell carcinoma, NOS, of floor of mouth, NOS

+∞

8.3

WB111

NOMESCO Finland

Multiple neoadjuvant cytostatic therapy

+∞

8.3

166

Kela drug reimbursment

Dalteparin and tinzaparin (treatment for more than 6 months)

+∞

8.3

JN6DR

NOMESCO Finland

PET-CT of whole body metabolism

10.9

8.3

R04.1

ICD-10 Finland

Haemorrhage from throat

14.6

8.2

SAA02

NOMESCO Finland

Basic examination of mouth

1.5

8.2

551

4580

N02AJ06

ATC

codeine and paracetamol; systemic

1.5

8.1

387

2996

C44.32

ICD-10 Finland

Spinocellular carcinoma of the skin on another or unspecified part of the face

33.7

8.1

EB1AA

NOMESCO Finland

Intraoral radiographic dental examination

1.5

8.1

472

3808

SPC20

NOMESCO Finland

Implant borne crown

10.1

8.0

A01AB10

ATC

natamycin; local oral

3.5

8.0

D04.3

ICD-10 Finland

Carcinoma in situ: Skin of other and unspecified parts of face

4.7

7.9

EDC38

NOMESCO Finland

Open reduction and fixation of fracture of body of mandible

13.2

7.9

GD1QA

NOMESCO Finland

Supine thorax X-ray examination

1.7

7.9

180

1179

T86

ICPC

Hypothyroidism/myxoedema

2.7

7.7

151

JDA08

NOMESCO Finland

Endoscopic removal of foreign body from stomach or pylorus

45.4

7.7

J01CR02

ATC

amoxicillin and beta-lactamase inhibitor; systemic

1.5

7.7

433

3455

A01AB09

ATC

miconazole; local oral

2.1

7.7

363

QX4AT

NOMESCO Finland

Ultrsound guided needle biopsy of skin

18.5

7.6

K12.18

ICD-10 Finland

Other forms of stomatitis

12.0

7.6

SCB02

NOMESCO Finland

Instructions for self-performed oral hygiene

25.2

7.6

JJ2AT

NOMESCO Finland

Biopsy of liver with ultrasound guidance

6.2

7.6

WX000

NOMESCO Finland

Monitoring vital functions without anesthesy

2.7

7.5

154

C32.1

ICD-10 Finland

Malignant neoplasm: Supraglottis

80.7

7.4

GBB13

NOMESCO Finland

Revision of tracheostomy

80.7

7.4

QAE20

NOMESCO Finland

Excision and repair of scar or web of skin of head or neck

13.5

7.4

XGX32

NOMESCO Finland

Bronchoscopic ultrasonography

11.0

7.3

2008X

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Other named variants

+∞

7.3

QAE30

NOMESCO Finland

Excision and repair of surgical scar in head or neck

+∞

7.3

9680/3-C01.9

ICD-O-3

Diffuse large B-cell lymphoma, NOS, of base of tongue, NOS

+∞

7.3

DQE00

NOMESCO Finland

Implantation of prosthetic replacement for larynx

+∞

7.3

L02BB03

ATC

bicalutamide; oral

+∞

7.3

C50.49

ICD-10 Finland

Malignant tumor of the upper outer quadrant of the mammary gland, other or undeterminated histology

+∞

7.3

KE3AT

NOMESCO Finland

Transrectal gold marker implantation in prostate under ultrasound guidance

+∞

7.3

8086/3-C01.9

ICD-O-3

Squamous cell carcinoma, HPV negative of base of tongue, NOS

+∞

7.3

C34.31

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung epidermoid carcinoma

+∞

7.3

C11.9

ICD-10 Finland

Malignant neoplasm: Nasopharynx, unspecified

+∞

7.3

8120/3-C67.9

ICD-O-3

Transitional cell carcinoma, NOS, of bladder, NOS

+∞

7.3

C34.1

ICD-10 Finland

Malignant neoplasm: Upper lobe, bronchus or lung

+∞

7.3

C06.0

ICD-10 Finland

Malignant neoplasm: Cheek mucosa

+∞

7.3

ZZQ10

NOMESCO Finland

Free microvascular graft of skin and muscle

+∞

7.3

T81.0

ICD-10 Finland

Haemorrhage and haematoma complicating a procedure, not elsewhere classified

2.3

7.3

249

SPF20

NOMESCO Finland

Temporary relining of dentures

6.3

7.3

ZY020

NOMESCO Finland

Telephone, letter or other consultation without direct patient contact

2.2

7.2

289

TEW99

NOMESCO Finland

Other minor procedure in surgery of teeth, jaws, mouth and pharynx

2.5

7.2

193

JN3AA

NOMESCO Finland

Abdominal X-ray examination without contrast

2.5

7.2

175

D28

ICPC

Limited function/disability (D)

30.3

7.2

ZXX04

NOMESCO Finland

Extent of procedure, 4 units

20.2

7.1

NK6AN

NOMESCO Finland

Total body bone isotope imaging

20.2

7.1

D37.7

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Other digestive organs

4.1

7.1

Z50.5

ICD-10 Finland

Speech therapy

5.7

7.1

UDC00

NOMESCO Finland

Ear microscopy

2.0

7.1

381

EMAK, ,

NOMESCO Finland

2.7

7.1

135

J38.0

ICD-10 Finland

Paralysis of vocal cords and larynx

4.0

6.9

R59.9

ICD-10 Finland

Enlarged lymph nodes, unspecified

7.6

6.9

EBA05

NOMESCO Finland

Complicated extraction of tooth

1.6

6.9

209

1462

J02.9

ICD-10 Finland

Acute pharyngitis, unspecified

2.6

6.8

149

D20

ICPC

Mouth/tongue/lip symptom/complaint

2.4

6.8

198

B37.09

ICD-10 Finland

Unspecified candidal stomatitis

5.7

6.8

NK6CT

NOMESCO Finland

Bone biopsy with CT guidance

40.4

6.8

JN5JR

NOMESCO Finland

Extensive PET-CT of upper body metabolism (eyebrows to thighs)

22.7

6.7

ZZR10

NOMESCO Finland

Flap of skin and muscle

22.7

6.7

UGB02

NOMESCO Finland

Tracheoscopy

22.7

6.7

H02AB06

ATC

prednisolone; systemic

1.4

6.6

403

3234

Z03.1

ICD-10 Finland

Observation for suspected malignant neoplasm

6.0

6.6

J01FF01

ATC

clindamycin; systemic

1.5

6.5

236

1711

OAB42, ,

SPAT

0.4

6.5

818

DQB10

NOMESCO Finland

Endoscopic excision of lesion of larynx

6.2

6.5

ECA30

NOMESCO Finland

Excision of lesion of gingiva

6.2

6.5

EJW99

NOMESCO Finland

Other operation on tongue or floor of mouth

70.3

6.4

WD505

NOMESCO Finland

Simple enzyme inhibitor or similar therapy of methastized malignancy

70.3

6.4

OAB38

NOMESCO Finland

Psychosocial guidance and counselling

70.3

6.4

KAC10

NOMESCO Finland

Total nephrectomy with capsule

70.3

6.4

PA6YT

NOMESCO Finland

Dilatation of carotid artery with stent

14.4

6.4

RS316, ,

NOMESCO Finland

14.4

6.4

AA1CD

NOMESCO Finland

Very extensive CT of head and brain

5.2

6.3

SPD05

NOMESCO Finland

Mucosa borne complete denture, demanding

11.1

6.3

K10.25

ICD-10 Finland

Sequences of jawbones

9.3

6.3

WW200, ,

SPAT

0.6

6.3

157

2257

WX700

NOMESCO Finland

Respiratory and circulatory monitoring

1.6

6.3

137

884

Z94.8

ICD-10 Finland

Other transplanted organ and tissue status

18.2

6.3

D37.9

ICD-10 Finland

Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified

18.2

6.3

C82.01

ICD-10 Finland

Follicular nodular lymphoma, grade I

+∞

6.3

8070/3-C10.9

ICD-O-3

Squamous cell carcinoma, NOS, of oropharynx, NOS

+∞

6.3

HAE10

NOMESCO Finland

Reconstruction of breast using graft or flap

+∞

6.3

YG1CD

NOMESCO Finland

Very extensive CT examination of thorax for dose design of radiotherapy

+∞

6.3

JAA96

NOMESCO Finland

Other local operation on abdominal wall

+∞

6.3

390

Kela drug reimbursment

Ibrutinib

+∞

6.3

C15.5

ICD-10 Finland

Malignant neoplasm: Lower third of oesophagus

+∞

6.3

8072/3-C09.9

ICD-O-3

Squamous cell carcinoma, large cell, nonkeratinizing, NOS, of tonsil, NOS

+∞

6.3

C03.0

ICD-10 Finland

Malignant neoplasm: Upper gum

+∞

6.3

C34.32

ICD-10 Finland

Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma

+∞

6.3

C15.9

ICD-10 Finland

Malignant neoplasm: Oesophagus, unspecified

+∞

6.3

EL3AN

NOMESCO Finland

Isotope imaging of salivary glands

+∞

6.3

WW402

NOMESCO Finland

Leucoferesis

+∞

6.3

B72

ICPC

Hodgkin Lymphoma

+∞

6.3

C50.11

ICD-10 Finland

Malignant tumor of the central part of the mammary gland,ductal tumor

+∞

6.3

C44.39

ICD-10 Finland

Malignant tumor of the skin on another or unspecified part of the face other or unspecified histology

+∞

6.3

2000B

ICD-9 Finland

Lymphosarcoma and reticulosarcoma, Reticulosarcoma[LYMPHOMA MALIGNUM DIFFUSUM]

+∞

6.3

8070/3-C32.9

ICD-O-3

Squamous cell carcinoma, NOS, of larynx, NOS

+∞

6.3

8310/3-C64.9

ICD-O-3

Clear cell adenocarcinoma, NOS, of kidney, NOS

+∞

6.3

KEC00

NOMESCO Finland

Retropubic radical prostatectomy

+∞

6.3

C80.91

ICD-10 Finland

Malignant tumor without specified localization epidermoid carcinoma

+∞

6.3

C77.8

ICD-10 Finland

Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions

+∞

6.3

C01BD, ,

ICD-10 Finland

+∞

6.3

C82.00

ICD-10 Finland

Follicular nodular non-Hodgkin's lymphoma, ungraded

+∞

6.3

JN6CD

NOMESCO Finland

Very extensive CT of torso and neck

+∞

6.3

GBB18

NOMESCO Finland

Closure of tracheostomy

+∞

6.3

C34.12

ICD-10 Finland

Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma

+∞

6.3

C83.00

ICD-10 Finland

Lymphocytic lymphoma

+∞

6.3

8083/3-C01.9

ICD-O-3

Basaloid squamous cell carcinoma of base of tongue, NOS

+∞

6.3

ZXX06

NOMESCO Finland

Extent of procedure, 6 units

26.9

6.2

DWD00

NOMESCO Finland

Reoperation for superficial heamorrhage in surgery of ear, nose and larynx

26.9

6.2

N02AA03

ATC

hydromorphone; systemic, rectal

26.9

6.2

K00.09

ICD-10 Finland

Lack of teeth due to lack of dental development UNS

3.7

6.2

XF400

NOMESCO Finland

ECG with 12 standard connections

1.6

6.2

146

960

D64.9

ICD-10 Finland

Anaemia, unspecified

1.8

6.2

100

594

K22.2

ICD-10 Finland

Oesophageal obstruction

6.3

6.2

Z71.2

ICD-10 Finland

Person consulting for explanation of investigation findings

1.5

6.2

234

1711

ZXE03

NOMESCO Finland

Procedure duration 20 to 29 minutes

2.3

6.2

201

ECB15

NOMESCO Finland

Plastic repair of oronasal or oroantral fistula

7.7

6.1

D70.89

ICD-10 Finland

Neutropenic splenomegaly

8.7

6.1

SPA48

NOMESCO Finland

Precision impression for denture, demanding

8.7

6.1

N05BA06

ATC

lorazepam; systemic, sublingual

2.2

6.0

216

K92.0

ICD-10 Finland

Haematemesis

2.9

6.0

100

SPF30

NOMESCO Finland

Relining of denture

3.3

6.0

L04.0

ICD-10 Finland

Acute lymphadenitis of face, head and neck

6.1

6.0

SPA47

NOMESCO Finland

Precision impression for denture

2.5

6.0

147

LabWAS

↥

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

(4035726) Immunohistochemistry procedure

435

227

35.29

307.65

1.6

1.3

—

(3043109) Cytology report of Tissue fine needle aspirate Cyto stain

196

28.32

276.91

1.3

1.2

—

(3012095) Magnesium [Moles/volume] in Serum or Plasma

502

1288

7.34

206.01

7.4

2.8

0.77

0.83

mmol/l

23.25

495

1209

(3013742) Prealbumin [Mass/volume] in Serum or Plasma

338

659

7.51

179.61

3.0

2.1

0.23

0.20

g/l

8.77

328

606

(40768804) Tissue Pathology biopsy report

609

2264

5.95

155.25

3.0

1.7

—

(40768795) Lymph node Pathology biopsy report

49.45

125.03

1.2

1.1

—

(3015377) Calcium [Moles/volume] in Serum or Plasma

539

2426

3.93

91.87

6.2

2.1

2.37

2.35

mmol/l

2.62

514

2119

(3002256) Pathology report gross observation

233

593

4.92

87.18

1.4

1.1

—

(3013650) Neutrophils [#/volume] in Blood by Automated count

731

4187

4.56

84.45

15.5

6.8

4.04

4.28

e9/l

2.07

660

3603

(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma

679

3893

3.80

73.47

10.5

4.2

10.27

12.59

umol/l

7.17

667

3698

(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal

158.27

70.04

1.1

1.2

—

(3024561) Albumin [Mass/volume] in Serum or Plasma

604

3370

3.28

64.99

7.1

4.1

35.01

35.89

g/l

3.20

583

3138

(3001079) Blood group antibody screen [Presence] in Serum or Plasma

588

3372

3.04

57.53

3.5

2.5

—

estimate

—

(3044640) Blood type and Crossmatch panel - Blood

453

2276

2.94

56.27

3.2

2.2

—

(42870588) Differential panel, method unspecified - Blood

460

2539

2.61

44.63

7.0

5.7

—

(3033658) Prothrombin time (PT) actual/Normal

374

1887

2.65

43.39

5.3

3.9

87.86

85.57

1.03

368

1845

(3006504) Eosinophils/Leukocytes in Blood

573

3554

2.61

42.94

7.9

6.0

2.72

3.04

2.44

547

3317

(3019069) Monocytes/Leukocytes in Blood

573

3555

2.61

42.90

8.0

6.2

9.62

9.13

2.65

549

3311

(3003458) Phosphate [Moles/volume] in Serum or Plasma

258

1081

2.92

42.90

5.9

0.98

1.02

mmol/l

2.03

248

996

(46236098) ABO and Rh group [Type] in Blood by Confirmatory method

355

1761

2.65

42.45

2.9

2.2

—

(3023368) Bacteria identified in Blood by Culture

414

2214

2.57

42.33

5.9

4.2

—

(3022096) Basophils/Leukocytes in Blood

572

3564

2.59

42.15

7.9

6.1

0.62

0.69

2.37

546

3316

(3008295) Osmolality of Serum or Plasma

7.13

42.07

1.3

1.4

285.58

276.42

mosm/kgh2o

1.59

(3001604) Monocytes [#/volume] in Blood

607

3911

2.61

41.32

7.7

5.9

0.62

0.61

e9/l

0.30

529

3342

(3006315) Basophils [#/volume] in Blood

607

3929

2.59

40.62

7.8

5.9

0.04

e9/l

2.40

526

3359

(3002030) Lymphocytes/Leukocytes in Blood

572

3620

2.52

39.87

8.1

6.1

23.23

27.17

13.05

553

3425

(3026389) Candida sp identified in Specimen by Organism specific culture

7.62

39.37

1.4

1.3

—

(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma

134

398

3.77

38.99

3.8

1.5

19.90

2.67

ug/l

0.88

113

295

(3019198) Lymphocytes [#/volume] in Blood

606

3989

2.51

37.98

7.9

5.9

1.67

1.85

e9/l

0.77

537

3496

(3013115) Eosinophils [#/volume] in Blood

613

4062

2.51

37.77

8.1

6.0

0.17

0.21

e9/l

5.17

543

3532

(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma

598

3931

2.47

37.29

9.8

6.7

1.21

mmol/l

0.10

522

3408

(3018010) Neutrophils/Leukocytes in Blood

560

3580

2.43

37.10

7.8

6.0

60.54

57.65

6.54

543

3408

(3021879) Hepatitis B virus core Ab [Presence] in Serum

137

430

3.57

36.63

1.3

1.6

—

(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma

785

5934

3.13

35.93

13.5

5.9

80.39

76.65

u/l

1.55

767

5574

(3018418) pH of Serum or Plasma

400

2235

2.39

35.63

5.3

3.5

7.40

0.90

299

1595

(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma

296

1467

2.50

34.16

5.3

2.0

2.49

2.44

mmol/l

7.38

276

1282

(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma

545

3537

2.32

33.51

8.9

6.3

1.21

1.20

mmol/l

0.25

519

3227

(3045142) Bone marrow Pathology biopsy report

11.33

33.04

1.4

1.2

—

(3007853) Bacteria identified in Skin by Aerobe culture

212

928

2.67

31.37

2.0

1.8

—

(3042111) Morphology [Interpretation] in Bone marrow Narrative

6.88

30.44

1.8

1.2

—

(3032080) INR in Blood by Coagulation assay

569

3890

2.20

29.07

15.5

16.6

1.22

1.31

inr

3.50

483

3246

(3003694) ABO and Rh group [Type] in Blood

356

2032

2.22

28.70

1.5

1.3

—

(3019284) Hepatitis B virus surface Ag [Presence] in Serum

174

740

2.66

26.96

1.4

1.5

—

(40758558) Short blood count panel - Blood

382

2298

2.13

26.43

10.7

4.7

—

(3013826) Glucose [Moles/volume] in Serum or Plasma

650

4786

2.20

26.17

7.5

5.1

6.47

6.81

mmol/l

4.83

630

4562

(3021589) Normoblasts [#/volume] in Blood

500

3409

2.02

23.79

16.3

10.3

0.00

e9/l

0.55

410

2795

(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection

177

4.00

22.77

1.6

1.4

—

(3017143) Hepatitis C virus Ab [Presence] in Serum

158

701

2.51

22.16

1.3

1.6

—

(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection

125

4.53

21.80

1.6

1.5

—

(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma

173

806

2.41

21.80

3.3

2.3

7.28

7.86

umol/l

0.16

160

718

(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection

181

3.79

20.51

1.6

1.4

—

(46236952) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)/1.73 sq M

153

696

2.44

20.23

3.2

2.4

68.71

64.47

ml/min/173m2

0.56

268

(3036481) Cortisol [Moles/volume] in Serum or Plasma

153

701

2.42

19.90

3.9

1.7

409.76

368.48

nmol/l

1.74

145

644

(46235355) HIV 1 and 2 tests - Meaningful Use set

186

929

2.25

19.81

1.4

1.7

—

(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture

190

963

2.22

19.50

1.4

—

(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection

123

519

2.58

19.03

1.9

1.5

—

(3000494) Fungus identified in Specimen by Culture

194

1024

2.13

17.84

1.7

1.4

—

(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma

395

2.69

17.09

1.2

123.29

135.78

u/ml

0.10

163

(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection

4.53

16.03

1.5

1.6

—

(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma

152

3.64

16.02

3.4

2.1

1987.47

45.36

u/ml

0.53

123

(3005702) Mycobacterium sp identified in Specimen by Organism specific culture

168

3.48

15.83

1.3

1.5

—

(3000991) Gas panel - Venous blood

154

778

2.18

15.70

10.5

9.3

—

(3010503) CD19 cells [#/volume] in Blood

7.12

15.31

2.1

2.2

989.48

166.18

e6/l

0.41

(3042936) Bacteria identified in Isolate by Culture

209

1197

1.96

15.13

2.1

—

(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method

6.71

14.52

1.1

1.5

—

(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection

4.15

14.38

1.7

1.5

—

(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection

227

1358

1.89

14.33

2.3

1.9

—

(3014702) Chromogranin A [Moles/volume] in Serum or Plasma

6.80

14.07

2.8

1.8

2.95

3.79

nmol/l

0.36

(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood

117

555

2.27

13.84

5.3

3.3

1.24

1.22

mmol/l

1.23

110

464

(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection

138

3.53

13.73

5.7

6.0

560.14

405.32

iu/ml

—

(3017181) Myelocytes/Leukocytes in Blood

129

642

2.17

13.57

6.0

4.2

1.20

0.65

1.18

130

(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection

165

3.28

13.47

1.4

—

(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture

149

788

2.06

13.37

4.3

3.3

—

(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma

699

5840

1.81

13.15

5.8

3.8

14.59

14.85

pmol/l

2.10

668

5310

(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count

210

1272

1.84

12.57

3.0

1.68

1.58

e6/l

0.07

109

617

(44790047) Parainfluenza type 1 nucleic acid detection

4.05

12.54

1.4

—

(44790049) Parainfluenza type 3 nucleic acid detection

4.05

12.54

1.4

—

(44806118) Parainfluenza type 4 nucleic acid detection

4.05

12.54

1.4

—

(44790048) Parainfluenza type 2 nucleic acid detection

4.05

12.54

1.4

—

(40765096) Chromosome analysis panel by Banding

14.57

12.30

1.2

1.1

—

(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma

10.69

12.30

3.4

2.0

0.61

0.59

mmol/l

0.76

(3027945) Reticulocytes/Erythrocytes in Blood

172

984

1.92

12.27

3.1

1.9

1.77

1.78

0.07

157

881

(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection

125

3.47

12.04

1.4

1.3

—

(3021440) Promyelocytes/Leukocytes in Blood

122

622

2.11

12.01

6.0

4.3

0.06

0.07

0.14

111

(3027946) Carbon dioxide [Partial pressure] in Arterial blood

178

1038

1.89

11.96

11.4

8.7

5.23

5.13

kpa

0.75

169

1007

(3027801) Oxygen [Partial pressure] in Arterial blood

178

1038

1.89

11.96

11.4

8.6

12.96

11.58

kpa

3.17

171

1009

(3002179) Metamyelocytes/Leukocytes in Blood

121

616

2.11

11.96

5.4

4.0

0.66

0.51

0.41

125

(3005719) IgG [Mass/volume] in Serum or Plasma

108

529

2.18

11.78

3.4

2.3

9.47

11.14

g/l

3.34

100

492

(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection

170

983

1.89

11.71

2.2

1.8

—

(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood

8.77

11.56

2.1

3.0

—

(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain

3.88

11.55

1.2

1.1

—

(3035933) Granulocytes/Leukocytes in Blood

139

3.27

11.50

3.3

2.9

61.37

58.98

0.49

139

(3019977) pH of Arterial blood

176

1037

1.86

11.41

11.5

8.7

7.41

0.10

590

(3003396) Base excess in Arterial blood by calculation

175

1032

1.86

11.31

11.4

8.6

1.44

1.11

mmol/l

0.51

157

862

(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection

177

1048

1.85

11.29

2.2

1.8

—

(21494434) Karyotype in Bone marrow

5.63

11.21

1.1

—

(3020460) C reactive protein [Mass/volume] in Serum or Plasma

846

7641

2.26

11.15

29.6

14.6

26.63

25.08

mg/l

0.72

797

6171

(3018095) Leukocytes [#/volume] in Urine

391

2895

1.61

10.88

4.0

3.7

119.14

118.07

e6/l

0.01

279

2068

(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay

3.72

10.87

3.1

1.9

115.24

36.71

u/ml

0.67

(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection

144

3.16

10.87

1.5

1.4

—

(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection

145

3.14

10.75

1.5

1.3

—

(3030467) Casts [#/volume] in Urine by Automated count

313

2211

1.63

10.48

3.4

3.1

0.32

0.38

e6/l

0.43

234

1615

(3035715) Granulocytes [#/volume] in Blood

113

3.37

10.22

3.3

3.2

4.68

4.54

e9/l

0.08

113

(3025159) Blasts/Leukocytes in Blood

119

641

1.98

10.04

6.3

4.4

0.09

0.00

0.99

103

(3016502) Oxygen saturation in Arterial blood

158

937

1.83

9.95

11.5

8.8

95.49

95.11

0.20

153

910

(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count

218

1421

1.70

9.88

2.9

2.8

0.98

0.95

e6/l

0.06

120

769

(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen

12.34

9.87

1.6

3.5

1.27

2.73

ratio

1.53

(3026782) Osmolality of Urine

224

1474

1.69

9.79

3.1

2.7

522.50

540.84

mosm/kgh2o

0.59

191

1280

(3002582) Erythrocytes [#/volume] in Urine

351

2599

1.56

9.40

3.5

3.2

61.66

92.25

e6/l

0.32

270

1991

(3000012) Reticulocyte production index

104

3.36

9.38

2.5

1.8

0.91

0.96

0.23

(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection

4.02

9.37

1.2

1.1

—

(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma

125

706

1.89

9.15

3.4

2.4

44.88

42.25

u/l

0.10

109

578

(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma

144

2.93

9.01

1.2

1.4

—

(40763571) Iron/Transferrin [Ratio] in Serum or Plasma

179

1132

1.72

8.99

2.2

2.7

22.02

23.66

0.67

171

1054

(40760892) CBC W Ordered Manual Differential panel - Blood

245

1683

1.62

8.95

7.1

4.3

—

(40768800) Prostate Pathology biopsy report

3.99

8.91

1.2

1.1

—

(3017115) Methotrexate [Moles/volume] in Serum or Plasma

+∞

8.34

7.9

0.0

0.39

—

umol/l

—

(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection

4.33

7.97

1.5

1.4

—

(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection

4.49

7.92

1.5

1.4

—

(3014037) CD3+CD4+ (T4 helper) cells/cells in Blood

4.49

7.92

3.1

2.5

35.92

46.09

1.16

(40768806) Pleura Pathology biopsy report

4.00

7.91

1.4

—

(3009214) Lutropin [Units/volume] in Serum or Plasma

185

2.56

7.85

1.4

11.40

5.87

u/l

2.10

150

(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count

9.51

7.80

3.7

1.9

1.77

1.25

0.30

(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma

128

2.89

7.77

1.3

1.4

160.60

165.72

au/ml

0.10

(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection

439

2.00

7.71

1.5

—

(3020779) Urea [Moles/volume] in Serum or Plasma

133

808

1.75

7.64

5.7

7.4

7.68

10.19

mmol/l

5.05

127

772

(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection

4.15

7.56

1.5

1.3

—

(3023520) Reticulocytes [#/volume] in Blood

127

764

1.77

7.55

3.7

2.0

69.69

69.56

e9/l

0.01

564

(3048929) Epstein Barr virus Ab [Presence] in Serum

195

2.49

7.53

1.2

—

(3003181) Sodium [Moles/volume] in Urine

166

2.60

7.43

1.7

1.4

62.82

60.58

mmol/l

0.09

132

(3031040) Bacteria [#/volume] in Urine by Automated count

576

4880

1.48

7.41

4.5

4.2

153.22

1843.29

e6/l

—

(21494814) CD8 cells/Lymphocytes in Specimen

7.73

7.40

1.7

2.8

32.88

22.62

1.52

(3016228) CD19 cells/cells in Blood

7.73

7.40

1.6

2.7

8.81

7.14

0.12

(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection

3.54

7.30

1.7

1.5

—

(36305247) Microscopic observation [Identifier] in Isolate by Gram stain

211

2.40

7.26

1.7

1.6

—

(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection

510

1.89

7.12

1.8

1.6

—

(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection

3.67

7.06

1.8

1.4

—

(3022948) Iron [Moles/volume] in Serum or Plasma

194

1330

1.58

6.96

2.3

2.7

11.97

13.29

umol/l

1.65

184

1239

(3004789) Transferrin [Mass/volume] in Serum or Plasma

183

1240

1.59

6.90

2.2

2.7

2.22

2.29

g/l

0.71

175

1152

(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection

3.31

6.87

1.6

1.4

—

(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma

334

2575

1.46

6.86

4.2

2.8

63.74

43.12

u/l

0.32

324

2421

(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood

4.06

6.64

2.0

1.5

0.55

0.71

e9/l

0.87

(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma

271

2016

1.49

6.63

2.2

2.3

2.79

2.78

mg/l

0.01

232

1725

(3009595) Pneumocystis jirovecii DNA [Presence] in Specimen by NAA with probe detection

3.34

6.17

1.5

1.6

—

(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum

3.29

6.03

1.1

—

(3013707) Erythrocyte sedimentation rate [Velocity] in Red Blood Cells by Westergren method

665

5896

1.45

6.03

5.0

4.3

14.38

11.35

mm/h

5.02

629

5497

(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection

3.44

5.89

1.9

1.2

—

(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection

3.44

5.89

1.9

1.2

—

(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection

3.44

5.89

1.9

1.2

—

(3016038) Potassium [Moles/volume] in Urine

3.33

5.89

1.3

1.1

27.37

34.55

mmol/l

0.77

(3028026) IgM [Mass/volume] in Serum or Plasma

430

1.86

5.84

2.0

1.4

0.95

1.18

g/l

1.05

401

(3004410) Hemoglobin A1c/Hemoglobin.total in Blood

716

7737

0.67

5.75

6.0

7.1

38.75

40.09

mmol/mol

4.24

670

7267

(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay

228

2.17

5.71

3.0

2.6

0.36

0.35

iu/ml

0.07

120

(4281824) Cell count and differential, peritoneal fluid

4.79

5.63

1.4

1.1

—

(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma

595

5213

1.40

5.44

3.7

3.3

63.94

50.50

u/l

1.21

566

4868

(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells

167

2.33

5.44

2.2

1.4

—

(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma

315

2488

1.40

5.39

3.5

2.5

50.97

61.26

u/l

3.72

296

2297

(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma

738

7908

0.67

5.34

4.8

5.5

1.43

1.39

mmol/l

1.54

679

7367

(3012516) Albumin [Mass/volume] in Urine

252

3206

0.71

5.18

3.0

3.6

46.51

45.45

mg/l

0.03

159

2139

(3019550) Sodium [Moles/volume] in Serum or Plasma

855

8079

1.77

5.09

32.4

18.4

138.89

139.85

mmol/l

17.81

846

7923

(40764999) Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)/1.73 sq M

814

7596

1.60

5.08

28.0

14.0

81.06

78.64

ml/min/173m2

3.37

774

7062

(40758292) HTLV I+II Ab panel - Serum

13.43

5.08

1.1

1.0

—

(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting

705

7604

0.69

5.05

4.2

4.7

1.29

1.34

mmol/l

1.09

644

7022

(3012336) Haptoglobin [Mass/volume] in Serum or Plasma

391

1.83

5.02

2.0

1.5

1.56

1.53

g/l

0.11

344

(3012441) Differential panel - Pleural fluid

3.00

5.01

1.1

1.4

—

(3009201) Thyrotropin [Units/volume] in Serum or Plasma

773

7148

1.50

4.87

6.9

4.8

2.72

1.98

mu/l

6.85

741

6557

(3019900) Cholesterol [Moles/volume] in Serum or Plasma

747

7961

0.68

4.83

4.9

5.6

4.54

4.49

mmol/l

0.66

692

7464

(3009508) Creatinine [Moles/volume] in Urine

262

3280

0.72

4.78

3.0

3.5

8.17

8.07

mmol/l

0.11

216

2808

(3020682) Albumin/Creatinine [Ratio] in Urine

260

3257

0.72

4.76

3.6

4.3

7.13

8.19

mg/mmol

0.27

156

2116

(40768793) Breast Pathology biopsy report

4.47

4.76

1.3

1.2

—

(3023103) Potassium [Moles/volume] in Serum or Plasma

855

8100

1.73

4.75

32.8

18.5

3.97

4.01

mmol/l

3.99

845

7931

(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection

296

1.91

4.71

1.9

3.0

—

(3008757) Leukocyte morphology finding [Identifier] in Blood

3.37

4.62

5.8

3.3

—

(3026008) Bacteria identified in Urine by Culture

262

2057

1.38

4.51

3.3

3.1

—

(3042631) Mycobacterium sp identified in Specimen

105

2.52

4.49

2.1

2.8

—

(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture

3.04

4.41

2.7

2.4

—

(3026493) Urate [Moles/volume] in Serum or Plasma

282

2261

1.36

4.21

4.1

2.6

349.59

364.18

umol/l

1.57

258

1970

(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma

376

1.75

4.17

3.7

3.4

4.12

4.53

pmol/l

2.75

330

(3016650) Hepatitis A virus Ab [Presence] in Serum

128

2.31

4.16

1.1

—

(3002032) Base excess in Venous blood by calculation

133

937

1.49

4.13

3.7

3.3

2.61

1.97

mmol/l

1.02

121

819

(3012544) pH of Venous blood

136

964

1.48

4.09

3.9

3.4

7.39

7.38

0.36

550

(3021447) Carbon dioxide [Partial pressure] in Venous blood

135

956

1.48

4.08

3.8

3.3

6.09

5.86

kpa

1.47

128

929

(3037756) Immunofixation for Serum or Plasma

130

2.27

4.03

1.8

1.2

—

(3028308) Erythrocytes [#/volume] in Pleural fluid

2.70

4.01

1.4

1.5

17530.42

118351.76

e6/l

0.68

(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

404

3443

1.31

3.88

2.3

2.4

78.28

77.11

nmol/l

0.34

372

3073

(3025941) Bacteria identified in Stool by Culture

347

1.75

3.85

1.4

1.3

—

(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay

153

2.13

3.82

1.2

1.4

—

(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay

153

2.13

3.82

1.2

1.4

—

(3045788) Cell count panel - Pleural fluid

2.60

3.56

1.3

1.5

—

(3007164) IgA [Mass/volume] in Serum or Plasma

178

1359

1.38

3.56

1.8

1.3

2.35

2.78

g/l

2.24

110

814

(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma

4.11

3.40

7.7

1.1

21.16

63.42

u/ml

—

(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay

2.86

3.37

1.4

1.2

29.56

34.11

u/l

0.25

(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection

4.38

3.31

1.1

1.3

—

(3000850) Epithelial cells [#/volume] in Urine

224

1793

1.33

3.29

2.9

2.5

4.54

4.67

e6/l

0.05

202

1637

(3019225) pH of Specimen

102

717

1.47

3.22

4.1

3.7

7.35

7.36

0.34

474

(3052851) Hemolysis interference index of Serum or Plasma

194

1.89

3.15

3.9

3.5

3.52

1.57

index

1.01

101

(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection

3.28

3.14

1.0

1.1

—

(3051611) Lipemic interference index of Serum or Plasma

2.65

3.14

4.1

3.5

12.82

11.41

index

0.25

(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma

771

8078

0.73

3.13

5.5

6.4

2.64

2.62

mmol/l

0.22

710

7556

(3023199) Leukocytes [#/volume] in Pleural fluid

2.35

3.09

1.3

1.5

2793.50

1987.53

e6/l

0.23

(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma

213

1711

1.32

3.03

1.7

1.66

1.25

mg/l

1.09

174

1334

(3013327) Hepatitis A virus IgM Ab [Presence] in Serum

120

2.11

3.00

1.1

—

(3011363) Streptococcus pneumoniae Ag [Presence] in Urine

2.57

2.97

1.1

—

(3017044) Thyrotropin receptor Ab [Units/volume] in Serum

164

1.92

2.88

1.7

2.1

5.82

33.90

iu/l

—

(3001964) Herpes simplex virus Ag [Presence] in Specimen

5.42

2.87

1.9

1.7

—

(3000570) Elastase.pancreatic [Mass/mass] in Stool

216

1.79

2.84

1.5

1.4

269.86

305.73

ug/g

0.45

137

(3017732) Neutrophils [#/volume] in Blood

129

970

1.38

2.83

3.9

3.0

3.97

4.56

e9/l

1.44

114

833

(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum

195

1.83

2.79

1.1

1.4

—

(40761536) Microorganisms panel - Urine sediment

546

1.49

2.73

4.3

3.4

—

(3051651) Icteric interference index of Serum or Plasma

3.26

2.73

5.0

4.1

0.73

1.06

index

0.79

(3000093) Morphology [Interpretation] in Blood Narrative

2.45

2.72

1.4

1.1

—

(3020911) Cortisol [Moles/time] in 24 hour Urine

4.24

2.68

1.3

1.4

154.13

69.26

nmol/24h

—

(3007930) Methemoglobin/Hemoglobin.total in Blood

369

1.58

2.66

8.4

4.9

1.01

0.86

1.59

354

(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma

208

1694

1.29

2.65

4.6

4.3

502.46

549.52

ng/l

0.06

182

1415

(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood

2.68

2.63

2.2

2.5

—

(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum

141

1.94

2.62

1.1

1.2

280.88

268.86

u/ml

0.09

(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection

4.03

2.57

2.0

1.3

—

(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection

4.03

2.57

2.0

1.3

—

(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection

4.03

2.57

2.0

1.3

—

(3041678) Intrinsic coagulation system thromboelastography panel - Blood

7.17

2.55

1.4

—

(3015479) Mycobacterium sp identified in Blood by Organism specific culture

5.48

2.54

1.8

1.4

—

(3019150) Specific gravity of Urine by Refractometry

151

1896

0.76

2.53

4.4

3.9

1.02

kg/l

0.02

106

1244

(40768443) Skin Pathology biopsy report

302

1.62

2.52

1.1

1.2

—

(3004588) Protein electrophoresis panel - Serum or Plasma

549

1.46

2.48

3.7

1.4

—

(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection

3.49

2.48

1.9

1.2

—

(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection

3.49

2.48

1.9

1.2

—

(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection

3.49

2.48

1.9

1.2

—

(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection

3.49

2.48

1.9

1.2

—

(3037692) Legionella sp identified in Specimen by Organism specific culture

3.49

2.48

1.2

1.3

—

(3024354) Oxygen [Partial pressure] in Venous blood

107

802

1.38

2.41

3.3

2.8

4.65

4.50

kpa

0.27

777

(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection

205

1.74

2.40

1.5

1.2

—

(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma

853

8244

1.45

2.37

17.8

10.7

25.81

28.17

u/l

3.34

839

7990

(40768797) Stomach Pathology biopsy report

141

1106

1.32

2.36

1.3

—

(40768441) Liver Pathology biopsy report

3.05

2.36

1.2

1.6

—

(3019060) Gas panel - Arterial blood

530

1.45

2.35

5.6

5.1

—

(3014765) Yersinia sp identified in Stool by Organism specific culture

192

1.75

2.32

1.2

1.1

—

(3006418) Campylobacter sp identified in Tissue by Organism specific culture

192

1.75

2.32

1.2

1.1

—

(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood

407

1.51

2.30

8.1

4.7

1.65

1.68

0.09

392

(3003191) Choriogonadotropin [Presence] in Serum or Plasma

3.50

2.27

1.0

1.6

—

(42529406) Shigella sp [Presence] in Stool by Culture

194

1.73

2.25

1.2

1.1

—

(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection

225

1.67

2.24

1.6

1.3

—

(3025839) Triglyceride [Moles/volume] in Serum or Plasma

319

3621

0.82

2.21

1.9

2.0

1.35

1.38

mmol/l

0.19

264

3033

(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma

258

1.62

2.18

5.1

1.4

32.44

34.68

mg/l

0.13

215

(3034860) Kappa light chains.free [Mass/volume] in Serum

258

1.62

2.18

5.1

1.4

47.69

48.41

mg/l

0.03

214

(3043410) Blood group antigens tested for on Red Blood Cells

3.35

2.18

1.6

1.2

—

(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection

465

4214

1.21

2.17

2.8

2.5

—

(3033319) Streptococcus pyogenes Ag [Presence] in Throat

507

1.43

2.13

1.3

1.4

—

(40761511) CBC panel - Blood by Automated count

824

7944

1.34

2.08

23.1

13.3

—

(40760543) Extractable nuclear Ab [Presence] in Serum by Immunoblot

2.72

2.07

1.1

—

(3048879) Bone marrow aspiration report

5.02

2.07

2.8

1.0

—

(3023183) Ammonium ion [Moles/volume] in Plasma

201

1.67

2.01

4.2

3.2

32.08

38.16

umol/l

0.63

184

(3020564) Creatinine [Moles/volume] in Serum or Plasma

859

8343

1.41

2.00

36.4

19.4

79.94

82.54

umol/l

1.97

852

8243

(3015302) Jo-1 extractable nuclear Ab [Units/volume] in Serum

4.56

1.94

1.2

1.4

—

(3048821) Cortisol [Moles/volume] in Serum or Plasma --post 1 mg dexamethasone PO overnight

2.10

1.87

1.3

—

(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum

222

1.60

1.84

5.6

1.3

2.28

1.33

ratio

0.95

124

(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence

4.18

1.82

1.0

—

(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay

2.59

1.80

1.1

1.8

104.67

92.37

—

(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma

568

1.37

1.79

2.7

4.2

94.03

97.74

ng/l

0.10

505

(3012501) Base excess in Blood by calculation

140

1.73

5.0

4.8

2.94

2.98

mmol/l

0.02

(3008536) Aspergillus sp Ab [Presence] in Serum

3.86

1.71

2.6

1.0

—

(3006922) Hepatitis E virus Ab [Presence] in Serum

2.16

1.61

1.0

1.1

—

(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.01

1.58

3.2

3.4

10.03

10.38

kpa

—

(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood

3.01

1.58

3.2

3.5

4.55

4.98

kpa

—

(3001122) Ferritin [Mass/volume] in Serum or Plasma

374

3395

1.17

1.56

2.9

192.91

144.43

ug/l

2.38

351

3165

(3016616) Dehydroepiandrosterone sulfate (DHEA-S) [Moles/volume] in Serum or Plasma

3.35

1.52

1.0

1.1

2.00

3.72

umol/l

—

(3001684) Respiratory syncytial virus Ag [Presence] in Specimen

3.35

1.52

1.0

—

(3009340) Metanephrine [Moles/volume] in Serum or Plasma

1.84

1.52

1.9

1.4

—

nmol/l

—

(3013005) Retinol [Moles/volume] in Serum or Plasma

2.87

1.50

4.0

1.2

1.75

1.87

umol/l

—

(4034850) Laboratory test

306

0.58

1.50

5.9

9.2

—

(1761482) Bacteria [#/volume] in Urine by Culture

170

1.61

1.50

6.1

4.2

—

(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection

2.45

1.48

2.1

1.3

—

(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection

2.51

1.45

2.4

1.3

—

(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection

2.51

1.45

2.4

1.3

—

(1761868) Lipid panel - Serum or Plasma

277

3090

0.85

1.44

3.3

3.5

—

(3033799) Differential panel - Peritoneal fluid

2.74

1.43

1.8

2.0

—

(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence

181

1.56

1.41

1.2

—

570.59

—

(4198724) Urine methamphetamine measurement

2.62

1.37

1.8

2.0

—

(40767503) Oxygen content in Capillary blood by calculation

167

1.57

1.35

3.0

2.7

14.43

16.67

2.49

161

(36660697) Celiac disease serology panel - Serum

542

1.32

1.35

1.1

1.2

—

(3026179) Normetanephrine [Moles/volume] in Serum or Plasma

105

1.73

1.34

1.9

1.4

0.56

17.87

nmol/l

0.50

(3044007) Cell count panel - Peritoneal fluid

2.51

1.30

2.7

2.8

—

(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum

153

1.58

1.30

1.0

1.1

—

(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC

2.36

1.29

1.4

—

(3002619) Bacteria identified in Specimen by Culture

2.79

1.28

1.4

1.2

—

(40759836) Histone Ab [Presence] in Serum by Immunoblot

1.95

1.28

1.2

1.1

—

(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma

2.30

1.27

1.9

3.3

825.38

1006.74

u/ml

—

(3020650) Glucose [Presence] in Urine

2.41

1.24

1.0

1.9

0.00

0.12

estimate

—

(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot

1.92

1.23

1.2

1.1

—

(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot

1.92

1.23

1.2

1.1

—

(3024869) Neuronal Ab [Presence] in Serum

2.64

1.21

1.0

1.1

—

(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis

2.64

1.21

1.2

1.4

13.64

14.90

pmol/l

—

(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection

2.17

1.21

2.3

1.3

—

(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma

308

2804

1.15

1.18

2.5

2.2

230.39

282.24

u/l

0.30

294

2653

(3004716) Salmonella sp identified in Stool by Organism specific culture

291

1.39

1.17

1.8

1.3

—

(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot

1.94

1.17

1.2

—

(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma

117

985

1.22

1.15

1.7

1.9

1.89

1.60

1.22

858

(3006462) Nitrate [Presence] in Urine

2.34

1.12

2.3

3.1

—

(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot

1.91

1.12

1.2

1.1

—

(3019420) Tryptase [Mass/volume] in Serum or Plasma

2.01

1.12

1.3

1.4

5.71

6.20

ug/l

—

(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells

2.27

1.10

3.3

1.5

—

(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells

2.27

1.10

3.3

1.5

—

(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma

2.20

1.08

4.0

1.2

25.86

27.81

umol/l

—

(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing

186

1.47

1.07

1.4

1.7

—

(3016914) Bacteria identified in Cerebral spinal fluid by Culture

1.72

1.05

1.1

1.3

—

(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma

1067

0.82

1.04

9.7

6.6

—

(3007461) Platelets [#/volume] in Blood

860

8444

1.26

1.04

41.1

22.1

243.21

239.61

e9/l

0.71

849

8260

(3019309) Folate [Moles/volume] in Red Blood Cells

163

1430

1.17

1.03

1.8

1140.99

1141.96

nmol/l

0.00

113

1104

(3000475) Leukocytes [#/volume] in Synovial fluid

251

0.63

1.03

1.4

1.5

5570.38

15161.23

e6/l

—

180

(3026361) Erythrocytes [#/volume] in Blood

860

8445

1.26

1.03

41.0

22.1

4.29

4.57

e12/l

37.68

848

8230

(3010813) Leukocytes [#/volume] in Blood

860

8445

1.26

1.03

41.1

22.1

6.55

6.73

e9/l

1.23

847

8229

(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture

2.07

1.03

1.0

1.1

—

(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture

2.07

1.03

2.4

—

(4211845) Urine protein measurement

2.07

1.03

2.1

2.9

—

(3047181) Lactate [Moles/volume] in Blood

247

1.39

1.03

9.1

6.1

1.09

1.37

mmol/l

1.60

220

(3018333) Ribosomal P Ab [Presence] in Serum

1.90

1.01

1.2

1.1

—

(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip

287

3125

0.88

1.01

4.6

3.6

0.02

0.01

estimate

0.28

661

(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay

1.77

1.01

1.0

1.1

—

(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum

2.18

0.98

1.2

1.1

—

(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection

124

1.54

0.97

1.3

1.5

—

(21494755) Public health laboratory ask at order entry panel

634

0.78

0.97

1.2

1.4

—

(3006653) Thiamine [Moles/volume] in Blood

1.86

0.97

1.3

1.2

95.70

146.87

nmol/l

—

(40759850) Jo-1 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.75

0.96

1.2

1.1

—

(3028626) Oxygen [Partial pressure] in Capillary blood

216

1.40

0.96

3.4

3.1

7.50

7.96

kpa

0.93

211

(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma

1057

0.83

0.96

4.8

5.3

34.20

31.64

1.19

697

(3021960) Folate [Moles/volume] in Serum or Plasma

273

2499

1.13

0.95

1.9

1.7

21.48

19.82

nmol/l

1.05

236

2112

(3053028) Streptococcus sp identified in Specimen by Organism specific culture

1.90

0.94

1.0

1.1

—

(3028271) Lactate [Moles/volume] in Capillary blood

117

1.55

0.94

2.0

1.9

1.33

1.74

mmol/l

1.77

112

(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability

101

1.59

0.94

1.1

1.3

—

(3035320) C reactive protein [Mass/volume] in Body fluid

1.83

0.92

3.8

3.0

34.10

35.98

mg/l

—

(3010375) cycloSPORINE [Mass/volume] in Blood

2.15

0.91

27.0

25.8

121.00

135.35

ug/l

—

(3004451) EKG impression Narrative

1.73

0.86

1.6

1.3

—

(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma

158

1771

0.87

0.86

1.7

1.8

466.18

35873655.54

pmol/l

1.89

131

1483

(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot

1.68

0.85

1.2

1.1

—

(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum

534

0.78

0.85

2.0

2.6

13.35

15.21

au/ml

—

(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma

333

3562

0.90

0.84

4.0

3.8

21.14

23.65

2.47

152

1607

(42868678) Cholesterol non HDL [Moles/volume] in Serum or Plasma

566

0.78

0.84

1.8

1.9

3.58

3.45

mmol/l

0.38

428

(3028707) Methadone [Presence] in Urine by Screen method

1.70

0.82

2.1

1.7

—

(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma

793

0.82

2.2

2.3

3.48

3.61

ratio

0.44

653

(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma

418

0.76

0.80

1.8

2.0

46.72

41.06

nmol/l

0.49

399

(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection

295

1.30

0.79

2.2

1.6

—

(3045684) Alkaline phosphatase.other fractions [Enzymatic activity/volume] in Serum or Plasma

1.82

0.79

1.0

1.1

16.00

21.64

u/l

—

(3018301) Testosterone Free [Moles/volume] in Serum or Plasma

0.51

0.78

1.0

1.5

168.12

171.47

pmol/l

—

(3047007) Chlamydophila sp Ab [Presence] in Serum

0.51

0.78

1.0

1.3

—

(3039443) Prostate specific Ag panel - Serum or Plasma

280

0.71

0.78

1.7

1.6

—

(3036670) Protein [Mass/volume] in Synovial fluid

0.00

0.77

0.0

1.1

—

33.61

—

(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence

140

1.44

0.77

1.2

1.1

—

1.26

—

(3002222) Hepatitis E virus IgM Ab [Presence] in Serum

1.70

0.75

1.0

—

(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma

1.70

0.75

1.9

2.2

13.44

18.08

nmol/l

—

(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay

1.70

0.75

1.0

—

(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum

480

0.78

0.75

1.2

1.4

—

51.35

—

(3050449) Albumin [Mass/time] in Urine collected for unspecified duration

243

0.69

0.74

2.1

2.3

111.84

114.02

ug/min

0.01

148

(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma

420

4418

0.91

0.74

4.7

4.1

2.15

1.88

ug/l

1.12

373

4034

(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate

1.85

0.73

3.0

3.8

—

(3038515) Glucose [Moles/volume] in Venous blood

185

1.36

0.72

6.4

2.9

6.77

7.09

mmol/l

0.35

179

(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum

109

0.55

0.72

1.0

1.1

—

21.27

—

(3016251) Hemoglobin.gastrointestinal [Presence] in Stool

399

1.24

0.72

2.1

2.4

—

(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum

117

1315

0.87

0.68

1.2

1.3

2.72

11.46

u/ml

3.29

505

(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma

126

1409

0.88

0.68

1.3

22.26

32.49

iu/ml

0.96

415

(3050238) Crystals [Presence] in Synovial fluid by Light microscopy

249

0.72

0.67

1.3

1.4

—

(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma

357

3374

1.09

0.67

4.9

4.0

177.83

71.95

ng/l

0.32

298

2500

(3025130) Human papilloma virus identified in Specimen

1.63

0.67

2.0

1.4

—

(21491868) Cryoglobulin [Mass/volume] in Serum

1.79

0.66

1.0

1.2

—

0.07

—

(4062490) Immunoglobulin typing, IgG

1.55

0.65

1.0

1.2

—

(3009343) pH of Capillary blood

580

1.19

0.65

3.9

3.8

7.42

0.51

482

(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection

269

1.27

0.64

1.9

1.6

—

(3022145) Colonoscopy Study observation

815

1.16

0.64

1.4

—

(3027544) Mycobacterium sp identified in Sputum by Organism specific culture

1.48

0.64

3.9

4.6

—

(3021901) Oxygen saturation in Capillary blood

190

1.32

0.63

3.8

3.0

85.97

89.26

0.96

183

(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay

198

0.70

0.60

1.1

1.3

—

(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method

0.00

0.60

0.0

1.7

—

(4133840) Spirometry

0.00

0.60

0.0

1.2

—

(37208534) Antinuclear antibody arbitrary concentration in serum

0.00

0.59

0.0

1.0

—

(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma

264

0.75

0.58

1.3

1.2

1.57

1.48

g/l

0.81

264

(3011391) Calcitriol [Moles/volume] in Serum or Plasma

1.49

0.57

1.4

1.1

114.25

107.83

pmol/l

—

(3019832) Treponema pallidum Ab [Presence] in Serum

347

1.22

0.57

1.3

1.6

—

(1616796) Gas panel - Central venous blood

176

1.31

0.57

5.1

4.1

—

(3035400) Alkaline phosphatase.liver [Enzymatic activity/volume] in Serum or Plasma

1.67

0.56

1.0

1.1

102.00

78.39

u/l

—

(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)

1.63

0.55

1.5

1.2

1.05

1.08

ratio

—

(3021788) Differential panel - Synovial fluid

171

0.70

0.55

1.3

1.5

—

(1002224) Polysomnography panel

394

0.81

0.55

1.1

—

(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation

339

0.79

0.55

2.0

191.91

211.52

pmol/l

0.54

320

(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.58

0.54

1.2

1.1

—

(3022313) Gas panel - Capillary blood

405

1.20

0.54

4.0

3.9

—

(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma

1.54

0.53

1.0

1.1

98.00

249.46

iu/ml

—

(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection

1.45

0.52

2.2

1.2

—

(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma

859

0.87

0.51

2.6

2.5

9.96

9.12

ug/l

0.11

773

(3003338) MCHC [Entitic Mass/volume] in Red Blood Cells

663

6477

1.08

0.51

34.1

19.2

332.34

333.47

g/l

2.55

657

6446

(3027273) Bicarbonate [Moles/volume] in Venous blood

437

1.18

0.49

5.0

2.9

26.96

25.31

mmol/l

2.43

422

(3025468) Yersinia sp identified in Specimen by Organism specific culture

1.43

0.49

2.2

1.2

—

(3005988) Vibrio sp identified in Specimen by Organism specific culture

1.43

0.49

2.2

1.2

—

(3037121) Protein [Mass/volume] in Urine

262

1.23

0.49

3.4

3.0

303.74

321.96

mg/l

0.07

100

(3044941) Cell count panel - Synovial fluid

178

0.73

0.49

1.3

1.4

—

(3017446) Testosterone [Moles/volume] in Serum or Plasma

108

979

1.12

0.48

2.2

2.4

14.42

15.17

nmol/l

0.56

898

(3049717) Cytology report of Urine Cyto stain

291

1.21

0.47

3.0

1.8

—

(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid

191

1.26

0.46

1.3

547.00

762.96

e6/l

0.12

149

(3014973) Borrelia burgdorferi IgM Ab [Units/volume] in Cerebral spinal fluid

0.60

0.46

1.0

1.1

—

(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay

112

1.34

0.45

1.3

1.2

2.86

4.71

u/ml

—

(3024980) IgG subclass 4 [Mass/volume] in Serum

130

1.31

0.44

1.1

1.6

0.49

0.93

g/l

1.64

105

(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]

241

0.78

0.44

1.2

1.1

0.59

0.69

ratio

—

(3044242) Glucose [Moles/volume] in Arterial blood

1.43

0.42

2.5

1.9

8.52

7.90

mmol/l

—

(3019539) Treponema pallidum Ab [Titer] in Serum by Hemagglutination

0.65

0.42

1.8

2.5

—

1360.00

—

(3006442) Creatine [Moles/volume] in Serum or Plasma

1.41

0.42

1.6

83.75

88.58

umol/l

—

(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection

1.52

0.41

1.2

—

(3051101) Glucose [Moles/volume] in Cord blood

0.00

0.41

0.0

7.5

—

8.32

—

(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot

1.36

0.41

1.0

1.1

—

(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma

0.00

0.40

0.0

1.2

—

0.43

—

(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer

0.00

0.40

0.0

1.9

—

9.43

—

(3050129) First trimester maternal screen panel - Serum or Plasma

0.00

0.40

0.0

1.5

—

(3023419) Bacteria identified in Sputum by Culture

132

1.29

0.40

2.1

2.4

—

(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay

1.47

0.40

1.2

1.1

—

(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep

560

1.13

0.40

1.5

1.4

—

(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay

0.00

0.40

0.0

3.1

—

55.79

—

(3044927) Protein electrophoresis panel - Urine

104

0.67

0.39

1.1

—

(43054903) Holo-transcobalamin II [Moles/volume] in Serum

400

3864

1.06

0.39

2.3

2.1

92.40

94.42

pmol/l

0.43

212

2102

(21494890) Protein electrophoresis panel - 24 hour Urine

1.41

0.39

2.6

1.2

—

(3005322) IgE [Units/volume] in Serum or Plasma

505

0.86

0.39

1.3

351.05

308.14

u/ml

0.11

471

(3016628) Fibrinogen Ag [Mass/volume] in Platelet poor plasma by Immunoassay

0.00

0.39

0.0

1.2

—

0.64

—

(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma

0.00

0.39

0.0

1.7

—

15.96

—

(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma

0.00

0.39

0.0

1.1

—

(3017817) Protein [Mass] in Urine collected for unspecified duration

1.38

0.38

1.9

302.55

1405.05

2.90

(3005570) Glucose [Moles/volume] in Urine

1.38

0.38

1.4

1.6

—

(3024522) Salmonella sp identified in Specimen by Organism specific culture

1.35

0.38

2.2

1.2

—

(3023410) Appearance of Cerebral spinal fluid

1.35

0.38

1.5

1.3

—

(3012568) Campylobacter sp identified in Specimen by Organism specific culture

1.35

0.38

2.2

1.2

—

(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection

1.35

0.38

2.2

1.2

—

(3033705) Calcium.ionized [Moles/volume] in Venous blood

1.35

0.38

4.9

2.4

1.20

1.19

mmol/l

0.83

(3016543) Leukocytes [#/volume] in Cerebral spinal fluid

188

1.23

0.37

1.3

1.2

7.00

53.56

e6/l

0.79

142

(3013139) Helicobacter pylori Ag [Presence] in Stool

525

1.13

0.37

1.2

1.3

—

(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma

698

1.11

0.36

2.6

3.3

264.66

212.83

ng/l

0.39

645

(4268621) Lupus anticoagulant assay

1.36

0.36

2.4

2.3

—

(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence

0.64

0.35

1.0

1.2

—

(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain

126

0.71

0.35

1.4

1.5

—

(4024509) Urine culture

361

0.85

0.34

1.4

1.9

—

(3001788) Aldosterone [Moles/volume] in Serum or Plasma

100

1.30

0.33

1.2

1.5

238.31

368.74

pmol/l

1.22

(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose

0.68

0.33

1.0

1.2

7.80

7.53

mmol/l

—

(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay

0.67

0.33

1.0

1.1

—

(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal

313

1.16

0.32

1.0

1.1

—

(3041354) Potassium [Moles/volume] in Venous blood

1.31

0.32

4.9

2.4

3.99

4.12

mmol/l

1.17

(3035285) Chloride [Moles/volume] in Venous blood

1.31

0.32

4.9

2.4

107.17

105.50

mmol/l

0.98

(3006184) Hemoglobin [Mass/volume] in Capillary blood

211

1.19

0.31

2.2

2.3

117.89

133.37

g/l

1.92

166

(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation

505

1.12

0.30

3.7

3.6

2.81

2.09

mmol/l

0.66

370

(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum

325

1.14

0.30

1.1

1.3

—

(3038177) Helicobacter pylori Ab [Presence] in Serum

102

1.28

0.30

1.2

—

(3020876) Protein [Mass/time] in 24 hour Urine

1.29

0.30

2.1

1.9

0.48

2.31

g/24h

—

(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence

1.27

0.30

1.0

1.5

—

455.00

—

(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay

185

0.81

0.30

1.0

1.1

—

3.87

—

(3034770) Mitochondria Ab [Titer] in Serum

223

1.17

0.28

1.1

1.2

—

1856.00

—

(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay

112

1.25

0.28

1.4

1.3

1.71

2.15

u/ml

—

(3021601) Nitrite [Presence] in Urine by Test strip

422

4114

1.05

0.28

4.2

3.6

0.00

estimate

-0.00

106

806

(3048689) Calprotectin [Mass/mass] in Stool

848

1.08

0.27

1.9

2.5

140.67

177.38

ug/g

0.70

692

(3032773) Endomysium IgG Ab [Titer] in Serum

1.20

0.26

1.0

1.1

—

(3051387) C reactive protein [Mass/volume] in Capillary blood

169

1.19

0.26

4.0

3.3

32.39

28.61

mg/l

0.29

119

(3014148) Varicella zoster virus Ab [Titer] in Serum

0.66

0.26

1.2

1.1

—

(3022621) pH of Urine by Test strip

618

1.09

0.25

2.8

2.5

6.06

6.00

0.26

414

(3011648) Oxygen content in Venous blood

106

1.23

0.23

1.4

2.2

11.35

10.52

0.28

106

(3024891) Influenza virus A+B Ag [Presence] in Specimen

190

1.16

0.23

1.2

—

(3014051) Protein [Presence] in Urine by Test strip

223

2152

1.05

0.23

3.3

2.8

0.00

0.04

—

(3015736) pH of Urine

337

3283

1.04

0.23

3.5

3.3

6.36

6.22

1.34

179

1844

(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay

1.22

0.22

1.0

1.1

—

(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma

1.22

0.22

1.6

2.0

77.80

55.77

umol/l

—

(3000620) Complement C3 [Mass/volume] in Serum or Plasma

229

1.14

0.22

2.2

1.6

1.23

1.15

g/l

0.64

218

(3023420) DNA double strand Ab [Units/volume] in Serum

346

0.89

0.21

2.3

1.8

5.89

6.83

iu/ml

—

(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative

0.00

0.21

0.0

1.0

—

(42529527) Centromere protein A Ab [Units/volume] in Serum by Line blot

0.00

0.21

0.0

1.0

—

(3043238) Trisomy 21 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.6

—

(3047352) Trisomy 18 risk [Likelihood] in Fetus

0.00

0.21

0.0

1.5

—

(3016330) Potassium [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.4

—

(3005033) Fetal Nuchal fold Thickness US

0.00

0.21

0.0

1.5

—

1.23

—

(3000213) Normetanephrine [Moles/time] in 24 hour Urine

0.00

0.21

0.0

1.1

—

2.39

—

(3009015) Lactate [Moles/volume] in Synovial fluid

0.00

0.21

0.0

1.2

—

7.16

—

(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection

0.00

0.21

0.0

1.7

—

(3011335) Digoxin [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

2.8

—

0.61

—

(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

52.10

—

(3045462) Protein/Creatinine [Ratio] in Urine

0.00

0.21

0.0

4.4

—

14.58

—

(3001019) Free T4 and TSH panel - Serum or Plasma

268

1.12

0.21

2.7

1.8

—

(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.5

—

0.88

—

(3015401) Amylase [Enzymatic activity/volume] in Pleural fluid

0.00

0.21

0.0

1.5

—

12.13

—

(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age

0.00

0.21

0.0

1.5

—

(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma

0.00

0.21

0.0

1.5

—

1.07

—

(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight

0.00

0.21

0.0

1.5

—

0.92

—

(36304052) Adalimumab Ab [Units/volume] in Serum or Plasma

0.00

0.21

0.0

1.7

—

(3044290) Cell count panel - Cerebral spinal fluid

174

1.15

0.19

1.3

1.2

—

(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay

212

1.14

0.19

1.5

1.2

—

(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma

118

1.19

0.19

1.1

1.56

1.52

g/l

0.23

104

(3017569) Oxygen content in Arterial blood

1.19

0.18

1.6

2.1

13.41

16.70

—

(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay

121

0.82

0.18

1.5

—

(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma

256

2626

0.97

0.17

3.1

2.8

0.72

0.70

ug/l

0.20

177

1665

(3008037) Lactate [Moles/volume] in Venous blood

224

1.12

0.17

6.5

2.8

1.44

1.56

mmol/l

0.40

217

(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum

153

1584

0.96

0.16

1.3

1.06

1.51

u/ml

0.41

448

(3008898) HLA-B27 [Presence]

211

0.90

0.13

1.1

—

(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method

109

0.82

0.13

1.0

—

(3020891) Body temperature

455

0.94

0.11

5.1

4.6

36.96

36.93

°c

0.40

448

(3004616) Nuclear Ab [Presence] in Serum

115

0.87

0.10

1.6

1.3

—

(3002523) Influenza virus A Ag [Presence] in Specimen

115

0.87

0.10

1.1

—

(3003740) Influenza virus B Ag [Presence] in Specimen

115

0.87

0.10

1.1

—

(3049804) Myeloperoxidase IgG Ab [Units/volume] in Serum

239

0.92

0.10

1.3

1.2

—

7.08

—

(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing

1.06

0.09

1.0

—

(3018251) Fasting glucose [Moles/volume] in Serum or Plasma

782

7787

1.03

0.09

5.0

5.5

5.93

6.09

mmol/l

3.09

738

7150

(3029937) Albumin [Presence] in Urine by Test strip

234

2302

1.02

0.09

4.3

3.8

0.00

estimate

0.50

737

(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection

451

0.95

0.09

1.4

1.7

—

(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum

0.81

0.08

1.0

1.1

—

3.43

—

(3041096) Erythrocytes [Presence] in Urine by Automated

210

2134

0.98

0.08

4.2

3.1

0.57

0.00

estimate

0.49

623

(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection

123

0.89

0.08

1.5

2.2

—

(3009261) Glucose [Presence] in Urine by Test strip

422

4182

1.02

0.08

4.3

3.7

0.00

0.02

estimate

1.46

743

(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma

281

2776

1.02

0.07

3.4

3.2

1263.54

1343.29

ng/l

0.11

253

2387

(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay

108

1.11

0.07

1.0

1.2

111.33

114.36

0.12

101

(4195642) Thrombophilia screening test

112

0.89

0.07

1.0

1.2

—

(3035350) Ketones [Presence] in Urine by Test strip

420

4165

1.02

0.07

4.2

3.7

17.94

2.15

estimate

0.42

106

815

(4146454) Self-monitoring of blood glucose

104

0.86

0.06

2.7

—

(3037522) Nuclear Ab [Titer] in Serum

107

1050

1.02

0.05

1.4

1.3

459.31

522.38

titre

0.23

252

(3032700) Glomerular basement membrane Ab [Units/volume] in Serum

1.11

0.05

1.0

1.2

—

(4094501) Cardiovascular stress test using bicycle ergometer

282

0.96

0.04

1.1

—

(3003327) Ova and parasites identified in Stool by Light microscopy

230

1.04

0.03

1.3

1.8

—

(3000492) Spirometry study

797

1.02

0.03

1.4

1.5

—

(3020961) Endomysium IgA Ab [Titer] in Serum

300

1.03

0.03

1.1

—

158.88

—

(44816559) Phosphatidylethanol [Mass/volume] in Blood

379

0.98

0.02

1.6

1.7

0.43

0.38

mg/l

0.18

193

(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection

407

0.98

0.01

1.3

1.7

—

(4010399) Spirometry for bronchospasm with prolonged evaluation after bronchodilator

686

0.99

0.00

1.4

1.5

—

(3027944) Amphetamines [Presence] in Urine

156

1.03

0.00

1.8

1.5

—

(3011288) Drugs identified in Urine by Screen method Nominal

1.02

0.00

2.4

1.8

—

(3045424) Erythrocytes [Presence] in Urine

379

1.00

0.00

2.4

2.1

0.00

2.17

estimate

0.51

117

(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection

137

1.02

0.00

1.5

2.2

—

(3045414) Leukocytes [Presence] in Urine

751

1.00

0.00

2.3

2.0

0.00

0.02

estimate

0.50

147

(3016879) Cocaine [Presence] in Urine

149

1.01

0.00

1.8

1.6

—

(3016921) Smith extractable nuclear Ab [Units/volume] in Serum

229

1.00

0.00

1.5

1.2

1.77

2.64

u/ml

—

(3028300) Cannabinoids [Presence] in Urine

159

1.01

0.00

1.8

1.5

—

(3027008) Opiates [Presence] in Urine

159

1.01

0.00

1.8

1.5

—

(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum

227

1.01

0.00

1.5

1.2

4.73

4.35

u/ml

—

(3017766) Complement C4 [Mass/volume] in Serum or Plasma

225

1.02

0.00

2.3

1.6

0.27

0.23

g/l

0.75

217

(3000764) Benzodiazepines [Presence] in Urine

155

1.03

0.00

1.8

1.5

—

(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method

115

0.96

0.00

1.0

1.1

—

(36306063) Golimumab Ab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

2.2

—

(21491866) Provasopressin.C-terminal [Moles/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.1

—

13.35

—

(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method

0.00

0.0

1.8

—

(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay

0.00

0.0

1.6

—

36.20

—

(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay

0.00

0.0

1.4

—

(3033888) Pepsinogen I [Mass/volume] in Serum or Plasma

0.00

0.0

1.2

—

59.68

—

(3025549) Creatine [Moles/time] in 24 hour Urine

0.00

0.0

1.2

—

(3025886) Oxalate [Mass/time] in 24 hour Urine

0.00

0.0

1.2

—

30.24

—

(3027570) Oxalate [Moles/time] in 24 hour Urine

0.00

0.0

1.6

—

389.38

—

(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose

0.00

0.0

1.6

—

8.43

—

(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture

0.00

0.0

1.4

—

(3027974) Hepatitis B virus e Ag [Presence] in Serum

0.00

0.0

1.6

—

(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine

0.00

0.0

1.0

—

(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum

0.00

0.0

1.0

—

23.44

—

(3034092) Cytoplasmic Ig cells/cells in Blood

0.00

0.0

16.3

—

0.18

—

(3047166) Epithelial cells [#/area] in Urine sediment by Automated count

0.00

0.0

2.4

—

0.38

—

(3027401) Testosterone Free/Testosterone.total in Serum or Plasma

0.00

0.0

2.2

—

1.32

—

(3045519) Venlafaxine [Moles/volume] in Serum or Plasma

0.00

0.0

1.2

—

422.76

—

(3008691) Amylase [Enzymatic activity/volume] in Peritoneal fluid

0.00

-0.00

0.0

1.0

—

1112.33

—

(3032868) Hemoglobin electrophoresis panel in Blood

0.00

-0.00

0.0

1.2

—

(3016426) Methylmalonate [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.2

—

208.67

—

(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay

0.00

-0.00

0.0

1.0

—

(3051659) 25-hydroxyvitamin D2 [Moles/volume] in Serum or Plasma

0.00

-0.00

0.0

1.0

—

(3012447) Hantavirus puumala IgG Ab [Titer] in Serum

100

1.00

-0.00

1.1

—

(40765089) Chromosome analysis panel - Blood by G-banded

0.00

-0.00

0.0

1.0

—

(3009876) Amylase isoenzyme 3 panel - Serum or Plasma

0.00

-0.00

0.0

1.3

—

(3013762) Body weight Measured

0.00

-0.00

0.0

1.7

—

(3017704) Immunofixation for Urine

0.98

-0.00

1.0

1.1

—

(3016018) Differential panel - Cerebral spinal fluid

0.92

-0.00

1.5

1.2

—

(3013945) Hepatitis B virus e Ab [Presence] in Serum

0.00

-0.00

0.0

1.0

—

(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection

0.94

-0.00

1.0

1.2

—

(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection

0.94

-0.00

1.0

1.2

—

(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid

0.00

-0.00

0.0

1.5

—

(40762887) Creatinine [Moles/volume] in Blood

0.00

-0.00

0.0

2.2

—

(1001926) Buprenorphine [Presence] in Urine by Screen method

120

1.00

-0.00

1.6

1.4

—

(3007302) Hemoglobin [Mass/volume] in Mixed venous blood

0.00

-0.00

0.0

11.3

—

99.83

—

Mortality – FinRegistry

↥

This endpoint is excluded (different definition than used in FinnGen).

Relationships between endpoints

↥

Index endpoint: C3_TONSIL_BASEOFTONGUE_WIDE – Malignant neoplasm of tonsil and base of tongue, including Hilmo

GWS hits: -

This endpoint is excluded (different definition than used in FinnGen).

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

Malignant neoplasm of tonsil and base of tongue, including Hilmo

Endpoint definition

Endpoint definition steps

FinnGen

Phenotype data

1. Apply sex-specific rule

2. Check conditions

3. Check pre-conditions, main-only, mode, registry filters

4. Check minimum number of events

5. Include endpoints

6. Filter based on genotype QC (FinnGen only)

All original rules

Similar endpoints

Case counts by codes

Upset plot

Case counts by code for Malignant neoplasm of tonsil and base of tongue, including Hilmo (C3_TONSIL_BASEOFTONGUE_WIDE)

Summary Statistics

-FinRegistry-

-FinnGen-

Key figures

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

CodeWAS

Matched cohort

LabWAS

Mortality – FinRegistry

Relationships between endpoints